Development of an independent MU calculation methodology for treatments with small fields by Guilherme Filipe Pinto Campos
Development of an
independent MU
calculation
methodology for
treatments with
small fields
Guilherme Filipe Pinto Campos
Mestrado em Física Médica
Departamento de Física e Astronomia
2019
Orientador
Anabela Gregório Dias, PhD, Instituto Português de Oncologia do Porto
Francisco Gentil, EPE
Coorientador
Ana Catarina Santos Souto, MSc, Instituto Português de Oncologia do Porto
Francisco Gentil, EPE

Todas as correções determinadas
pelo júri, e só essas, foram efetuadas.
O Presidente do Júri,
Porto, / /

Agradecimentos
Este espac¸o e´ dedicado a todos aqueles que contribuı´ram para o desenvolvimento desta
tese, de forma direta ou indireta.
Em primeiro lugar, uma nota de agradecimento a`s orientadoras, Prof. Anabela Dias e
Prof. Catarina Souto pela orientac¸a˜o do trabalho, tempo despendido, disponibilidade,
dedicac¸a˜o e assisteˆncia.
Ao Prof. Joaquim Agostinho e a` Prof. Carla Rosa, que apo´s a primeira entrevista para
entrar no Mestrado, acreditaram nas minhas capacidades para concluir o grau
acade´mico.
Aos meus colegas de trabalho que me apoiaram para ingressar no Mestrado.
A` minha entidade empregadora (Ju´lio Teixeira, S.A.) por me deixar exercer func¸o˜es como
Te´cnico de Radioterapia dosimetrista no Instituto CUF Porto e realizar este Mestrado em
simultaˆneo sem qualquer contrapartida.
A` minha famı´lia e amigos, pelo apoio incondicional ao longo destes anos.
i
ii
Resumo
O desenvolvimento de te´cnicas de estereotaxia no passado permitiu o tratamento de
pequenas leso˜es malignas e na˜o malignas, numa u´nica ou em va´rias frac¸o˜es de
tratamento, com mais precisa˜o e com uma maior dose de radiac¸a˜o ao tumor. Para
assegurar a correta precisa˜o dos tratamentos de estereotaxia, os departamentos de
fı´sica dos servic¸os de radioterapia devem ter um programa exaustivo de controlo de
qualidade. Mu´ltiplas guidelines internacionais recomendam a verificac¸a˜o independente
do output calculado com um me´todo de ca´lculo alternativo.
O desenvolvimento de uma calculadora independente de unidades monitor (MU) com
correc¸o˜es de heterogeneidades foi proposto como objetivo principal deste trabalho, para
um Varian TrueBeam™ STx (6FFF e 10 FFF) e um Varian Novalis Tx™ (6X SRS)
usando cones estereota´xicos. Mu´ltiplas medidas em profundidade, perfis de dose e
output factors foram medidos em ambos os aceleradores lineares usando um detetor
apropriado para medic¸o˜es de campos pequenos. As medidas seguiram o formalismo de
dosimetria para campos pequenos proposto pelo TRS-483, o qual foi publicado em
Novembro de 2017.
Duas interfaces gra´ficas foram criadas em MATLAB®, uma interface para a importac¸a˜o e
processamento de dados do feixe a partir de ficheiros PTW MEPHYSTO mc2 ou a partir
dos dados de refereˆncia da Varian e outra interface para importac¸a˜o de dados do doente
e ca´lculo de MU, com e sem correc¸a˜o de heterogeneidades.
Os algoritmos desenvolvidos para ca´lculo de MU com e sem correc¸a˜o de
heterogeneidades foram extensivamente testados usando um fantoma de to´rax
QUASAR™ e um fantoma Lucy® 3D QA. Todos os testes de validac¸a˜o em fantomas
passaram com a excec¸a˜o de um teste de validac¸a˜o sem correc¸a˜o de heterogeneidades.
Para os doentes, a diferenc¸a ma´xima de 5% entre a dose planeada e absorbida e´
largamente aceite para assegurar que o tratamento e´ seguro e efetivo. Mu´ltiplos
doentes com planos de tratamento em ambos os aceleradores lineares foram testados.
Apenas um campo de tratamento em dois doentes diferentes excedeu a toleraˆncia
aceite com correc¸a˜o de heterogeneidades.
Palavras-chave: radiocirurgia, dosimetria de campos pequenos, cones estereota´xicos,
correc¸a˜o de heterogeneidades, TRS-483.
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Abstract
The development of stereotactic techniques in the past allowed the treatment of small
malignant and non-malignant lesions, in single or multiple fractions, with more accuracy
and a higher dose of radiation to the tumour. To ensure the correct accuracy of
stereotactic treatments, radiotherapy physics departments should have an exhaustive
quality assurance program. Several international guidelines recommend the
independently verification of the computer calculation output with an alternative
calculation method.
The development of an independent monitor unit (MU) calculator with heterogeneity
correction was proposed as the main objective of this work, for a Varian TrueBeam™
STx (6 FFF and 10 FF) and a Varian Novalis Tx™ (6X SRS) using stereotactic cones.
Multiple depth curves, dose profiles and output factors were measured in both linear
accelerators using an appropriate detector for small field measurements. The
measurements followed the dosimetry formalism for small fields proposed by the
TRS-483, which was published in November 2017.
Two graphical interfaces were created in MATLAB®, one interface for beam data import
and processing of PTW MEPHYSTO mc2 files or Varian golden beam data files and
another interface for patient data import and MU calculation, with and without
heterogeneity correction.
The developed algorithms of MU calculation with and without heterogeneity correction
were extensively tested using a QUASAR™ thorax phantom and a Lucy® 3D QA
phantom. All the phantom validation tests passed with an exception of one field in the
validation test without heterogeneity correction.
For patients, a maximum difference of 5% between the planned dose and the absorbed
dose is widely accepted to ensure that the treatment is safe and effective. Multiple
patients with treatment plans on both linear accelerators were tested. Only one
treatment field of two different patients exceeded the tolerance accepted with
heterogeneity correction.
Keywords: radiosurgery, dosimetry of small fields, stereotactic cones, heterogeneity
correction, TRS-483.
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1 Introduction
Today cancer is the second cause of death around the globe [1]. Each year, 14 million
of new cases of cancer are diagnosed [2]. Half of the patients diagnosed with cancer
can benefit from radiotherapy, 50% with curative intent and another 50% with palliative
relief [2]. World Health Organization estimates that 9.6 million people died in 2018 from
cancer [1]. In Portugal the cancer incidence is rising 3% each year. The mortality rate is
also increasing but slowly. Although we have more patients diagnosed with cancer, the
success of cancer treatment is growing [3].
Radiotherapy is used to treat cancer with high-energy particle or waves such as X-rays,
gamma rays, electron or proton beams [4]. It can also provide local control or symptom
relief in cancers that are locally advanced or disseminated [3]. The development of
stereotactic techniques allows the treatment of small lesions in the brain with more
accuracy. Radiosurgery patients receive a high dose of radiation in the tumour area that
needs to be treated, while nearby regions receives low doses because of the sharp dose
fall-off provided by stereotactic cones or multileaf collimators (MLC).
The technique choice depends on the tumour size and the proximity within critical
structures. Stereotactic radiosurgery (SRS) is administrated in a single fraction to small
intracranial lesions while fractionated stereotactic radiotherapy (FSRT) is used for large
lesions or those in close proximity to critical structures. FSRT balances the tumour
control and the damage to normal tissue [5]. A diameter of 3 cm on its maximum extent
is the size limit commonly accepted to make SRS [6], [7].
The objective of this work is the development of an independent MU calculator for
stereotactic treatments with Varian and BrainLAB cone systems in a Varian TrueBeam™
STx and Varian Novalis Tx™ using photon flattening filter free (FFF) energies (6 FFF /
10 FFF) and 6X SRS, respectively. The independent MU calculator developed will take
into account tissue heterogeneities, overcoming the main limitation of the Cone Dose
Calculation (CDC) algorithm used in radiosurgery treatment dose calculations.
This work will follow the new dosimetry formalist for small fields proposed by the
International Atomic Energy Agency (IAEA) TRS-483: Dosimetry of Small Static Fields
Used in External Beam Radiotherapy.
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2 Stereotactic Radiotherapy/Radiosurgery
2.1 Historical Background
SRS was first described in 1951 by Swedish neurosurgeon Lars Leksell. He used a
stereotactic frame of his own design coupled with a 200 kV X-ray therapy machine to treat
patients for trigeminal neuralgia. Leksell’s strategy of precise stereotactic localization of
a target and their irradiation with a focused beam of X-rays was the first example of a
minimally invasive procedure called radiosurgery, which has proliferated extensively since
then [8].
Leksell Gamma Knife was the first commercially available radiosurgical treatment device
in 1968 [9]. This system consisted of 179 60Co sources aimed at an isocenter. Each
source was collimated by a fixed collimator and with a helmet. Beams had a circular
shape with nominal diameters of 4, 8, and 14 mm at the isocenter [10]. The result was
a spherical dose distribution with sharp dose falloff [11]. This provided an alternative
treatment to certain neurosurgical procedures that were treated with needles before the
development of Gamma Knife with significant morbidity [9]. Stereotaxis refers to the
use of a three-dimensional coordinate system to localize intracranial targets and has
been more recently extensively developed in extracranial clinical situation. It delivers high
doses of ionizing radiation with great conformality and a very high geometrical precision
in single fractions (SRS) or multiple fractions (FSRT) [8]. Both techniques nowadays
are used because of the advances in medical imaging, computer technology, software
development and radiation-delivery technology [9].
SRS was developed to treat malignant and non-malignant structures in the cranial vault.
However, the administration of high doses in a single fraction can produce considerable
side effects in normal tissues surrounding the target volume. FSRT combines the
precision of target localization and dose application of SRS with radiobiological
advantage because it allows the deoxyribonucleic acid (DNA) of the normal tissue to
repairs itself during the time between fractions [12].
In the eighties conventional radiation therapy devices were adapted for special
procedures by the addition of specialized collimators and other devices that allowed
stereotactic radiosurgery techniques. Many of these improvements were custom made
for each clinical facility [8]. The proliferation of stereotactic treatments in linear
accelerators began with the introduction of the non-invasive Gill-Thomas-Cosman frame
that could subsequently be repositioned with a displacement < 1 mm [8].
Novalis was the first linear accelerator (LINAC) able to perform both SRS and FSRT
treatments. The first unit was installed in the state of California in 1997. This LINAC
employed circular collimators (from 5 to 60 mm in diameter) attached to an accessory
tray and a mini-multileaf collimator (with central leaves of 3 mm, adjacent leaves of 4.5 mm
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and outer leaves of 5.5 mm) with a maximum field size of 10x10 cm2 at the isocenter [8].
Another LINAC dedicated to SRS and FSRT was the Neurotron 1000. This device is
now commercialized by Accuray under the trade name of CyberKnife®. This machine
features a compact LINAC mounted on an industrial robotic arm. It is a purely image-
guided device that relays on stereoscopic planar imaging, multiple non-coplanar and non-
isocentric beams onto fixed or moving targets in the head or body of the patient [13].
2.2 Overview of the Varian Novalis Tx™ and Varian TrueBeam™ STx
systems
Varian Novalis Tx™
The Novalis LINAC provides an integrated system with technology developed by both
Varian and BrainLAB, featuring a treatment planning system, an automated patient
positioning with image-guidance and a treatment delivery LINAC (figure 1). In this way,
possible problems related with the communication between the different systems and
vendors are avoided because the treatment chain is integrated in all process [8].
The equipment is very similar to the Varian Trilogy® with its on-board imaging capabilities
(on-board imager® (OBI) and MV panel), however the MLC is slightly different. This has
a high definition MLC (HD-MLC) with a total of 60 leaf pairs (32 inner leaf pairs of 2.5 mm
width at the isocenter and 14 outer leaf pairs on either side (28 total) with 5 mm width
at the isocenter), providing a maximum field size of 40x22 cm2 when using MLC. It has
multiple photon and electron beam energies (6 and 15 MV for photons and 6, 9, 12, 15,
18 and 22 MeV for electrons), with a maximum dose rate of 600 MU/min for standard
beams and 1000 MU/min (SRS mode) for 6 MV photon beams. This higher dose rate is
achieved with a different flattening filter but it restricts the maximum field size to 15x15
cm2 [14].
A set of conical collimators of 4, 6, 7.5, 10, 12.5 and 15 mm are accessible with the
Novalis Tx™ model. Each cone aperture considers the beam divergence, reducing the
penumbra, achieving a steeper dose gradient. Cones are securely fixed to the gantry
thought a collimator mount with a bayonet locking mechanism. This system possesses
software and hardware interlocks to ensure the correct choice of the collimator is inserted
and the delivery of radiation outside the area shielded by the cone is avoided with the
limitation of the secondary collimator settings [13].
The Novalis family system come with an integrated treatment planning system (TPS)
(BrainSCAN and iPlan® RT). The iPlan® RT supports image fusion between different
imaging modalities, automatic segmentation of the critical relevant structures for brain,
spine, head and neck, and prostate treatments. It supports different treatment options
including static conformal arcs, conformal beams, dynamic conformal arcs, cones and
intensity modulated radiation therapy (IMRT). There are two algorithms for dose
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calculation: Pencil Beam and Monte Carlo. The latter takes into account the LINAC head
geometry, secondary electrons and tissue inhomogeneities, commonly found in extra
cranial treatments. However, Novalis Tx™ can deliver treatments planned with other
TPS such as Varian Eclipse™ and Philips Pinnacle, since they all provide integrated
treatment planning technologies for radiosurgery [13].
The ExacTrac® system is composed of two sets of equipment: two kV X-ray imaging
units and an IR-based optical positioning system. The sources of the X-ray units are
installed on the floor (on either side of the LINAC) and the amorphous silicon flat panel
is mounted diagonally on the ceiling [14]. The IR-based system is composed by a pair of
infrared video cameras that triangulate an external set of fiducial markers (Body Marker
Array) which is fixed to the thorax and/or abdomen of the patient [13]. The fusion of the
orthogonal planar images with the digital reconstructed radiograph (DRR) created in the
planning computed tomography (CT) scan provide the translations and rotations that are
corrected with the Brainlab ExacTrac 6D Robotic Couch.
Figure 1: Varian Novalis Tx™ overview of its LINAC, couch and imaging systems. Image from Varian Medical
Systems.
Varian TrueBeam™ STx
The TrueBeam™ STx (figure 2) is an advanced linear accelerator fully integrated for
image-guided radiotherapy and radiosurgery. It features multiple photon and electron
beam energies (2.5, 6, 10 and 15 MV for photons and 6, 9, 12 and 15 MeV for
electrons), a high-definition multi-leaf collimator with the same specs as the Novalis
Tx™ and a treatment couch with six degrees of freedom for the most accurate patient
alignment possible [15]. It also includes the ExacTrac® system developed by BrainLAB.
The linear accelerator is controlled by the new Maestro control architecture that
synchronizes dosage, motion and imaging for a fast and efficient treatment [16].
5
FCUP
Development of an independent MU calculation methodology for treatments with small fields
It offers both flattened and FFF beams. FFF beams allow faster treatments because the
removal of the flattening filter increases the dose rate. FFF beams are available at 6
MV FFF and 10 MV FFF with a maximum dose rate of 1400 MU/min and 2400 MU/min
respectively.
Figure 2: Varian TrueBeam™ STx overview of its LINAC, couch and imaging systems. Image from Varian
Medical Systems.
TrueBeam™ STx is bundled with the SRS Intracranial solution from Varian that enables
SRS treatments to be delivered with precision and efficiency. The SRS Intracranial
solution includes [17]:
• Optical Surface Monitoring System (OSMS) – a non-ionizing 3D imaging technology
that reconstructs the 3D surface data referenced to the isocenter. It allows a highly
accurate tracking of cranial positions even with non-coplanar beams. A display
shows the motion in all six degrees of freedom and may be viewed throughout
treatment;
• Integrated Conical Collimator Verification & Interlock (ICVI) – a system that
provides a robust and verifiable method of mounting and verifying conical
collimators. The ICVI system checks if the corrected cone size is attached,
according to the treatment plan. An incorrect cone size triggers an interlock,
increasing the patient safety. The 7 conical collimators have the following sizes: 4,
5, 7.5, 10, 12.5, 15 and 17.5 mm;
• Eclipse™ Cone Planning – A dedicated TPS that provides planning and dose
calculation using conical collimators. It supports frame or frameless
immobilization.
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2.3 SRS/FSRT Treatment Planning
The SRS/FSRT treatment is planned using a brain CT scan. Often a magnetic resonance
imaging (MRI) is fused with CT scan in order to provide better tumour delineation.
2.3.1 Computed Tomography Imaging
The stereotactic coordinates are used to define the volume which has to be irradiated,
therefore, target volume and organs at risk are localized in the space defined by the
stereotactic coordinates system. The localizer is a box with fiducial markers on each
plane that defines the link between the stereotactic coordinates and the imaging
coordinates so that any point in the 3D stereotactic coordinates can be determined [10].
The patient realises the CT scan on the Frameless Radiosurgery Imaging Support
(FRIS) on the CT couch. After the mask preparation and cooling the CT scan is acquired
following the institution protocol.
Other imaging modalities can be used complementarily with CT images for volumes
definition, such as MRI and angiography and less frequently positron emission
tomography (PET) and single-photon emission computed tomography (SPECT) [10].
2.3.2 Stereotactic devices
Stereotactic treatment implies the use of a device that can precisely direct the radiation
to a specific site of the body [9]. For FSRT treatments the head is fixed non-invasively in
a thermoplastic mask attached on the stereotactic frame [10]. Recently were developed
frameless stereotactic techniques that use optical and radiographic methods.
Independently of the device, the purpose is to provide an accurate coordinate system to
direct radiation to the target [9].
There are different stereotactic frame systems like: Brown-Roberts-Wells (BRW),
Cosman-Roberts-Wells (CRW), Leksell, Leibinger-Fischer and the BrainLAB system.
Each system differs from each other in the material of the frame, design, connection with
the localizer and the positioner and the accuracy [10].
2.3.3 Treatment Planning
After the delineation of the target volume and organs at risk that may get significant
dose, the isocenter is defined. This point is located inside the target volume and must
be positioned with precision in the isocenter of the treatment machine. In the case of
multiple lesions more than one isocenter can be defined. The TPS outputs the position of
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the isocenters in stereotactic coordinates that are used to correctly position the patient.
The position step is done with a positioner (or localizer) attached to the stereotactic frame
that allows the connection between the stereotactic coordinate system and the room
coordinate system [10].
There are multiple collimation choices for stereotactic treatments. For circular or oval
target volumes, stereotactic conic collimators can be used. Stereotactic conic collimators
are tertiary collimators with diameter usually between 1 and 35 mm that can be attached
to the LINAC. If the target volume is irregular, micro MLC can be used. The decreased
leaf width has advantages in comparison with the traditional MLC. In this way, MLC leaves
can be adjusted individually to the tumor shape. Micro MLC also permits the possibility of
dynamic fields during irradiation and allows the implementation of IMRT and field shaping
with dynamic arcs [10]. Stereotactic cones, however, have a higher mechanical stability
and a sharper dose fall-off compared to MLC because of the smaller source-to-collimator
distance and focused cone aperture in contrast to the round shape of the MLC leaf ends
[18].
The radiation techniques in a conventional LINAC are, in general, isocentric and
implemented with a rotational technique using conic collimators or dynamic fields.
Static-field technique can also be used [10].
2.3.4 Positioning and radiation delivery
The positioning is done with the stereotactic positioner that allows the projection of the
coordinates of the isocenter onto the orthogonal planes attached to the stereotactic
frame. This way, the patient can be positioned so that the isocenter of the plan and the
isocenter of the LINAC defined by the room-based lasers overlap. After positioning the
patient, the positioner is removed and the treatment can start [10].
It is important to know that the mechanical stability and precision of the LINAC has to
be much better than in the conventional radiation treatment [10] in order to provide sub-
millimeter accuracy [9]. The axis of gantry rotation, the central axis of the beams and
the rotation axis of the rotation table should convert to the isocenter within a fraction of a
millimeter over all rotational angles that are used clinically [9].
TG-142 introduces new recommendations for quality assurance tests of medical linear
accelerators that are capable of SRS and SBRT with higher tolerances for this type of
treatments. The most notable mechanical tolerances that differ from conventional
treatment techniques are the laser localization, the collimator size indicator and the
treatment couch position indicators [19]. These differences are shown on table 1 and
table 2.
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Table 1: TG-142 daily mechanical tolerances for 3D-CRT and SRS/SBRT techniques.
Mechanical tolerance (daily tests) 3D-CRT SRS/SBRT
Laser localization 2 mm 1 mm
Collimator size indicator 2 mm 1 mm
Table 2: TG-142 monthly mechanical tolerances for 3D-CRT and SRS/SBRT techniques.
Mechanical tolerance (monthly tests) 3D-CRT SRS/SBRT
Treatment couch position indicators 2 mm / 1º 1 mm / 0.5º
Localizing lasers ± 2 mm < ± 1 mm
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3 Small fields dosimetry
Radiation dosimetry measures the absorbed dose or dose rate resulting from the
interactions of ionizing radiation with matter [20]. It is essential for the quantification of
the various biological changes as a function of the amount of dose received [21].
The success of radiotherapy depends on the accurate determination of absorbed dose
because of the dose-response curve for tumour control and normal tissue damage. A
small difference in the dose received by the tumour may compromise the tumour
eradication in case of under-dosage or complications in the normal tissue through
overdosage [22]. The steps involved in the determination of absorbed dose integrate
measurements with a detector (dosimeter) in a phantom (most of the times water) under
the radiation field [22].
Large developments in radiotherapy techniques and treatment units have led to a
proliferation of the use of small fields. The dosimetry of small fields is particularly
complex and prone to errors [8]. It is important to apply multiple levels of redundancy in
the determination of the absorbed dose by the use of different detectors with appropriate
detector correction factors for the measurements, analysis of measured data on other
similar equipment and corroboration of data with manufacturer reference data [8].
The reference dosimetry of high energy photons used in external radiotherapy is
currently based on code of practices or dosimetry protocols such as the TRS-398 and
TG-51. These codes of practices are based on measurements with ionization chambers
that have calibration coefficients in terms of absorbed dose to water. The reference
conditions for these calibration coefficients specify a reference field size of 10x10 cm2.
The IAEA and the American Association of Physicists in Medicine (AAPM) decided to
develop internationally standardized recommendations for the dosimetry of small static
photon fields up to 10 MV for machines that cannot establish the conventional 10x10
cm2 reference field in external radiation therapy. The result of that work culminated in
the publication of IAEA TRS-483, which is the first international code of practice
dedicated to the dosimetry of small fields for specialized radiotherapy equipment able to
produce small fields and for conventional LINACs with and without flattening filter [23] .
This code of practice introduces a new type of reference field for beam calibration: the
machine specific reference (msr ) field for treatment units that cannot establish the
conventional 10x10 cm2 reference field.
3.1 Physics of small fields
A photon beam is considered small if one of the following conditions is fulfilled [24]:
• There is a loss of lateral charged particle equilibrium (LCPE) on the beam axis;
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• There is a partial occlusion of the photon source by the collimating devices on the
beam axis;
• The size of the detector is similar or large compared to the beam dimensions.
3.1.1 Lateral charged particle equilibrium
Transient charged particle equilibrium (TCPE) regions are defined as zones where, past
the build-up region, absorbed dose and collision kerma are related to a slowly varying
function. In photon beams, TCPE exists not only in the longitudinal direction but also in
the lateral direction. Charged particles may leave the central axis to regions outside the
central axis. This effect compensates the charged particles that do the opposite way and
is called LCPE [24].
Loss of LCPE occurs when the beam half width or radius is smaller than the maximum
range of secondary electrons that contribute measurably to the absorbed dose. The
smallest field dimension for which LCPE condition exist is related by an important
parameter, lateral particle distance (rLCPE) [24].
The field size is often defined by the field diameter at the isocenter and can be
determined by the full-width at half maximum (FWHM) of the dose profile in a phantom
at the isocenter. For broad beams the field size is equal to the collimator aperture
projected at the isocenter. However, for small fields, the FWHM exceeds the collimator
aperture projected at the isocenter. If the radius of the field is smaller than rLCPE , the
penumbra of the field overlaps with the detector resulting in a sharp reduction in
machine output when the field size decreases (figure 3). This effect is energy dependent
because the range of secondary electrons is affected by the photon energy [24].
Figure 3: Effect of overlapping penumbrae on the FWHM illustrating the apparent field widening compared
to the collimator settings. The blue line corresponds to the ideal field dose profile (ideal FWHM) and the
distance marked as red to the real dose profiles. Image adapted from The physics of small megavoltage
photon beam dosimetry (Pedro Andreo, 2017).
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The rLCPE defined by TRS-483 was calculated using Monte Carlo simulations and can
be obtained as a function of the photon beam quality index, TPR20,10(10), or %dd(10, 10)x
in centimeters [24]:
rLCPE = 8.369× TPR20,10(10)− 4.382 (3.1)
rLCPE = 0.07797×%dd(10, 10)x − 4.112 (3.2)
3.1.2 Partial source occlusion
The primary photon source has origin in the bremsstrahlung target which has a spot size
with finite dimensions. In consequence, there will always be a field size (created by the
collimation system) that is occluded by the collimators. This results in photon penumbra
overlapping which reduces the output with further reduction of the field size. The width of
the beam profile is also increased to a value that does not match the nominal collimator
size projected at the isocenter, resulting in an apparent widening of the field. Partial
occlusion of the primary photon source influences the particle spectrum, as explained
below (3.1.4), and is a source of steep local absorbed dose gradients, both of which can
have a large effect on the detector response [24].
Figure 4: Illustration of the source occlusion effect. Image adapted from The physics of small megavoltage
photon beam dosimetry (Pedro Andreo, 2017).
3.1.3 Volume effect
The signal generated by the detector is proportional to the average absorbed dose over
its sensitive volume and is affected by the homogeneity of the dose over the detection
volume. A field is called small if the ionization chamber used for dosimetry becomes too
large to give reliable results. Small field conditions can be assumed to exist when the
distance of the external edge of the detector volume and the field edge is smaller than
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rLCPE in the medium. To avoid this condition, the beam half width or radius has to be at
least as large as rLCPE plus half size of the external volume of the detector. [24].
3.1.4 Consequences of decreasing the field size
Two important aspects need to be considered in the dosimetry of small fields when
decreasing the field size. The hardening of the energy spectrum and its influence on the
water-to-air stopping-power ratios for ionization chamber reference dosimetry [25].
Changes in the energy spectrum of small photon beams arise from two different
sources: changes in the treatment head when shaping small fields and changes in the
phantom or patient when field size is reduced. The collimator that defines a small field
shields photons that are scattered from different components inside the LINAC head
including flattening filter (if present) and primary collimator. Thus, the number of low
energy photons scattered by the primary collimator, flattening filter and other
components in the LINAC head reaching the center of the small field is reduced. The
amount of phantom or patient scatter also decreases for small fields when compared to
broad fields. In small fields and for most depths, this has a larger effect than the reduced
head scatter. Both effects lead to a hardening of the photon energy spectrum at any
point of the beam axis with decreasing field size and an increase in the average photon
energy (figure 5). This changes the ratio of mass energy absorption coefficients
between water and the detector material and a potential change of the stopping power
between water and the detector material [24].
Figure 5: Monte Carlo calculated photon fluence spectra as a function of the photon energy for different
detectors at 10 cm depth for 6 MV photon beams for 0.5x0.5 cm2 and 10x10 cm2 field sizes. Image adapted
from The physics of small megavoltage photon beam dosimetry (Pedro Andreo, 2017).
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Stopping power ratios are the core component of the processing of converting absorbed
dose in the sensitive area of the dosimeter into absorbed dose to medium in the absence
of the dosimeter [25]. Although the photon fluence spectrum changes considerably with
the field size decrease, the charged particle spectrum produced in water is much less
affected. The water to air stopping-power ratio is found to decrease by no more than
0.5% at a depth of 10 cm in a 10 MV photon beam using field sizes between 0.3x0.3
cm2 and 10x10 cm2. Even over a range of depths from the depth of maximum dose and
30 cm, the variation does not exceed 1%. [24]
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4 Detectors for small field dosimetry
A dosimeter can be defined as an instrument or device that measures, directly or
indirectly, the absorbed dose deposited in its sensitive volume. A dosimeter must have
at least one physical property that is a function of the measured dosimetric quantity that
can be used for radiation dosimetry with proper calibration [26].
The ideal detector requirements for small field dosimetry in radiotherapy would have
several properties: high reproducibility and stability, linearity, dose rate and energy
response independence and a high spatial resolution.
• In radiation therapy dosimetry the uncertainty of a measurement can be expressed
in terms of accuracy and precision. The precision of a measurement specifies the
reproducibility of the measurements and can be estimated obtaining repeated
measurements. A high precision is associated with a small standard deviation of
these measurement results. The accuracy of a measurement is the proximity
between the true value and the expectation value of the measured quantity [26];
• Linearity: Ideally, the dosimeter reading should be linearly proportional to the
dosimetric quantity. Beyond a certain dose range the dosimeter may behave
non-linear. The linearity range and the non-linearity behavior depend on the type
of dosimeter and its physical characteristics [26];
• Dose rate dependence: Ideally, the response of a dosimetry system at two different
dose rates should remain constant [26];
• Energy dependence: Ideally, the energy response should be flat. In reality,
dosimetry systems are calibrated at a specified radiation beam quality and are
used over a wider energy range, which means that the variation of the response of
a dosimetry system with radiation quality requires correction [26];
• Spatial resolution: Since the dose is a point quantity, the dosimeter should allow the
determination of the dose from a small volume. The position of the point where the
dose is determined should be well defined [26].
4.1 Detectors for small field measurements
There are several types of dosimeters systems that can be used for dose measurement.
However, the choice of a detector for small field dosimetry is a hard task considering all
the requirements above described.
No single detector stands out as having characteristics to the ideal one, so, it is advised
to use at least two or three different types of detectors suitable for small fields dosimetry
[24].
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The most common used detector in relative dosimetry is the air-filled ionization chamber,
however, there will be always a field size below which volume averaging becomes too
large. Bellow that size only liquid ion chambers or solid-state detectors are appropriate
for dosimetry of small fields [24].
4.1.1 Ionization chambers
In radiotherapy essentially only one type of chamber is employed: the cavity chamber.
Another chamber with relevance to accurate dosimetry is the free-air ionization chamber,
used in order to realise air kerma standards that are the basis for the majority of cavity
chambers calibrations [22].
Ionization chambers exist in different shapes and sizes, depending on the specific
requirements. They have a gas filled cavity surrounded by a conductive wall with a
central collecting electrode. An insulator separates the outer wall and the collecting
electrode to reduce the leakage current. An outer electrode can be provided to further
reduce the chamber leakage. This electrode intercepts the leakage current and allows it
to flow to ground, bypassing the collecting electrode [26].
There are basically two types of cavity chambers: cylindrical (thimble type) and parallel-
plate (or plane-parallel).
Farmer is a popular cylindrical ionization chamber with 0.6 cm3 [22]. The chamber
construction should be as homogeneous as possible, although the central electrode is
aluminium with 1 mm diameter to ensure flat energy dependence. The wall material is of
low atomic number (tissue or air equivalent) [26]. Classic ionization chambers have a
volume of 0.3-0.6 cm3. From 0.01 to 0.3 cm3 are small and from 0.002 to 0.001 cm3 are
considered micro [24].
Parallel-plate ionization chambers have two plane walls, one as an entry window and
polarizing electrode and the other as the back wall and collecting electrode. This type of
ionization chamber is recommended for dosimetry of electron beams with energies below
10 MeV. They can also be used for surface dose and depth measurements in the build-up
region of mega-voltage photon beams [26].
4.1.2 Diamond detectors
Diamond has been considered a suitable material for small volume high-resolution
detectors due its radiation hardness, soft tissue equivalence (Z = 6), small size,
high-sensitivity and low leakage current [27]. However, it has some disadvantages such
as the need of pre-irradiation to stabilize the detector response and its dose rate
dependence. Since diamond detectors are manufactured with natural diamonds, the
detector response may vary from detector to detector because the sensitive volume
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radius can vary between 1.0 and 2.2 mm and the thickness can vary from 0.2 to 0.4 mm.
The long manufacturing time, the high cost and the lack of high-quality diamonds make it
difficult for their wide use in radiotherapy dosimetry [28].
In the last years, natural diamond detectors have been replaced by artificial chemical
vapour deposition (CVD) diamonds [24]. They are attractive due to their relative low-cost
availability and reproducibility of natural diamond crystals and unlike natural diamond
detectors, CVD diamond detectors reports low dose rate dependence.
4.1.3 Diodes detectors
A silicon diode detector is a p-n junction diode. There are n-Si and p-Si dosimeters,
depending on the base material. For radiotherapy dosimetry, only p-Si is suitable since it
is less affected by radiation damage and has smaller dark current [26]. During the
irradiation electron-hole pairs are created. Conduction occurs by the movement of
electrons in the conduction band and by motion of hole states in the valence band. The
number of charge carriers is controlled by doping the material with impurities.
Depending on the material used, the crystal (typically it is silicon) is given an excess or
deficit of free electrons that can carry electrical current. Negative charged current is
caused by an excess of electrons and a positively charged current is caused by an
deficit in electrons, giving an n-type and p-type semiconductor, respectively [22].
Silicon diodes typical have small sensitive volumes (< 0.2 mm3). By this reason, volume
averaging effects are small. However, angular dependence is not uniform due to the
internal construction and materials used. It is advised to use silicon diodes with the axis
of symmetry parallel to the beam axis. Diodes over-respond to low energy photons
causing differences in the mass energy absorption coefficients. However, in small fields,
contribution of low energy photons is low because the scattered radiation is reduced.
There are unshielded and shield diodes. Shield diodes have a high density material
(usually tungsten) to absorb low energy scattered photons. The presence of this
material increases the fluence of secondary electrons in silicon, increasing the mass
energy absorption coefficient of tungsten of low energy photon beams, causing
over-response of the diode. For this reason, the use of shielded diodes for OF
measurement is discouraged. Increasing the depth of measurement also causes an
over-response of shield diodes because the contribution of low energy scattered
photons increases with depth. However, the decreased dose-rate at larger depths may
lead to an under-response of the diode. For small fields, unshielded diodes are advised
[24].
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4.2 Other measurement devices
Other types of dosimeters systems can be used for dose measurement in small fields
such as: film dosimetry (radiochromic films), thermoluminescence dosimetry (TLD),
semiconductor dosimetry (silicon diodes and metal oxide semiconductor field effect
transistors (MOSFETs), alanine detectors, plastic scintillator detectors and gels. [26].
These detectors can be used only to validate the beam data obtained, however, they
cannot be used for the acquisition of the beam data for the optimization of the algorithms.
4.2.1 Radiochromic films
Radiographic films were known for its superior spatial resolution in 2D but they had to be
used with caution because of their known limited absorbed dose range, energy and
orientation dependence. They exhibited over-response at low absorbed dose to water
levels outside the field, leading to an increased sensitivity in low energy photons. The
radiographic film processing and readout procedures were essential for accurate
dosimetry [24].
A new approach in film technology are the radiochromic films [22]. They have the
advantages of old silver halid films (thinness, ruggedness, permanent record, high
spatial resolution) but without numerous disadvantages [29]. Radiochromic films are
self-develop and require no chemical processing to get a 2D image of the absorbed
dose distribution. They do not require a darkroom for their processing and are
insensitive to ambient light but they were reported to be sensitive to ultraviolet radiation
[24]. For megavoltage beams they are nearly tissue equivalent because the photon
mass energy absorption coefficients and electron mass collision stopping powers are
very similar to those of water. They show energy dependence, however, depending on
the composition, they have some degrees of energy dependence in the kilovoltage
X-Ray region [22].
Post irradiation, radiochromic films development is governed by the polymerization of the
diacetylene dye monomers [29]. They can be handled easily and can be read with a
regular transmission flat-bed scanner [22]. The readout procedures require accurate
absorbed dose to water calibration, careful investigation of spatial non-uniformity of the
film and scanner response and dependence on film orientation. Radiochromic films can
be used for measurement of absolute absorbed dose in the same way as others
dosimeters as long as there is an established conversion of the film response and dose
deposited in the film. Typically, that is made with a calibration curve established during
calibration process [29]. The film signal continues to develop for several hours after
irradiation, therefore, the film scanning must be performed in the same post-irradiation
interval as for the calibration film [24].
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Radiochromic films have some other disadvantages such as film darkening over time
and temperature sensitivity effects, however, its advantages already mentioned here give
radiochromic films a considerable advantage over radiographic films. They can be used
for measurements of small beam profiles, penumbrae and output factors where changes
in spectral components of a beam can occur and affect the output factor measurements.
4.2.2 TLDs
Thermoluminescence consists in the light emission from an insulator or from a
semiconductor following the the previous absorption from the source of X-rays or other
ionizing radiation. The amount of light emitted is proportional to the absorbed dose by
the irradiated material. Since the light intensity emitted by a solid is proportional to the
absorbed dose under favourable conditions, the absorbed dose can be evaluated with
appropriate calibration [30]. TLDs are well known for absorbed dose audit programmes
and in vivo dosimetry [24].
4.2.3 MOSFETs
MOSFETs are small silicone field-effect transistors. They can be used to measured dose
based on the change in the threshold voltage. Due to its small size, they have an excellent
spatial resolution and exhibit little attenuation of the beam, which is useful for in vivo
dosimetry. However, they are energy dependent and show directional dependence and
poor signal to noise ratio. Other disadvantages are its short lifespan and high cost [31].
4.2.4 Alanine
Alanine is a crystalline amino acid in which free radicals are formed at irradiation. The
induced radicals by the radiation can be detected by electron spin resonance
spectroscopy. The signal is proportional to the amount of radicals in the sample. This
substance may be used as a dosimeter because the radical concentration is a function
of the absorbed dose [32]. Alanine has the advantage of its density being close to the
water so the only perturbation os the volume averaging effect [24] and multiple read-outs
of the sample can be performed because the spin resonance spectroscopy does not
destroy the signal [32]. However, alanine has low sensitivity (doses of 10 Gy are
required to a reproducibility of less than 0.5%) and in general, the necessary
instrumentation is not available in hospitals [24].
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4.2.5 Plastic scintillator dosimetry system
A scintillator detector system consists of a plastic scintillator embedded in a small
polystyrene probe and optically coupled to an optical fibre light guide. A second optic
fibre, not connected to the scintillator, is used for subtraction of background and stem
effect. Both fibres are connected to two different but identical photomultiplier tubes [33].
Plastic scintillators are almost water equivalent in terms of electron density and they
match the water mass stopping power and mass energy absorption coefficient within 2%
for the range of energies used clinically. Plastic scintillators are nearly energy and dose
rate independent and they have a high spatial resolution due to its small size (about
1 mm3) [26].
4.2.6 Gel dosimetry systems
Gel dosimetry systems are true 3D dosimeters for relative dose measurements. The
dosimeter is, at the same time, the phantom that can measure the dose distribution in
3D. Gels are nearly tissue equivalent and can be divided in two categories: Frickle gels
and polymer gels. In Frickle gels, Fe2+ ions in ferrous sulphate solutions are dispersed
throughout gelatin. After irradiation, those ions are converted into Fe3+. The changes in
paramagnetic properties can be measured using nuclear magnetic resonance relaxation
rates or optical techniques, creating a 3D image of the dose distribution. In polymer gel,
nonomers are dispersed in a gelatin or agarose matrix. After irradiation, a polymerization
reaction occurs, resulting in a 3D polymer gel matrix that deppends of the absorbed dose.
The dose distribution can be obtained with nuclear magnetic resonance, CT scan, optical
tomography, vibrational spectroscopy or ultrasound [26].
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5 Cone Dose Calculation Algorithm
The CDC algorithm is used in Eclipse™ Cone planning system to calculate the dose
when stereotactic cone applicators are used in stereotactic radiosurgery treatments.
This algorithm uses Tissue Maximum Ratios (TMR), Off-Axis Ratios (OAR) and Output
factors (OF) to determine the absolute dose at any point within the irradiated volume.
The following chapters are based on the Eclipse Photon and Electron Algorithms
Reference Guide [34].
5.1 Dose Calculation Model
The dose, D, at any point, P , in the beam is determined as:
D(r, d, SSD, S) = MU×DRref×OFTMRmax(S)×TMR(d, S)×
(
SAD
SSD + d
)
×OAR(r, S)
(5.1)
Where:
• r = off-axis distance to the point of interest;
• d = depth to location of interest along central axis;
• SSD = source-to-skin distance;
• D(r, d, SSD, S) = dose at location of interest;
• MU = monitor units;
• DRref = reference dose rate =
(
Dref
MUref
)
, where, Dref is the absolute dose (Gy)
in water for the reference field size at the reference point at the calibration depth,
where MUref is the MU given to produce the reference dose for calibration;
• OF (S) = output factor =
(
DS
Dref
)
, where DS is the dose at a specific point on the
central axis (at the isocenter) with depth d, when conical collimator, S, is used, and
where Dref is the dose measured in the same spatial location and d, as DS , using
reference field size;
• OFTMRmax(S) = output factor at TMRmax(S),
OF (S) × PDD(S,SSD,dmax)PDD(S,SSD,d) ×
(
SSD+dmax
SAD
)2
where d is the depth used to measure
OF (S);
• TMR(d, S) = tissue-maximum ratio,
(
Dd
Ddmax
)
, where Ddmax is the dose at a specific
point on the central axis (at the isocenter), with maximum dose depth dmax of tissue
equivalent material overlaying the point, and where Dd is the dose at the same
spatial point with an arbitrary depth, d, of overlaying tissue equivalent material;
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• SAD = source-axis distance;
• OAR(r, S) = off-axis ratio,
(
Dr
Da
)
, where, Da is the dose on the central axis at depth,
d, and Dr is the dose at an arbitrary off-axis distance, r, with the same central-axis
depth, d.
5.2 Limitations of the Dose Calculation Model
This algorithm has several limitations:
• The algorithm approximates arc beams as multiple static beams by averaging the
TMR for each arc. The increment angle is configurable in TPS;
• Tissue inhomogeneity is not considered. All the CT values inside the body of the
patient are treated as water and the CT values outside the body are treated as
air. This limitation is generally acceptable in the head since most beam paths are
through approximately water equivalent densities;
• Obliquity of the beams. The beam axis is assumed to always be normal to the
patient contour and no consideration is made for beam obliquity. Due to the small
field sizes in radiosurgery, this error is negligible;
• The absence of backscatter near the cavities or where the beam exits is not
considered. This results in the displayed dose near the surface being higher than
the actual dose;
• The off-axis ratio is assumed to be independent of depth, and only dependent on
the distance from radiation source. This assumption is valid since the collimators
are small and span only the central area of the LINAC broad beam.
5.3 Required Beam Data Measurements
CDC needs specific measurements for performing dose distributions calculations. The
following measurements are required for configuring the algorithm:
• Absolute dosimetry for a reference field;
• Output Factors for all cones relative to absolute dosimetry reference field;
• Tissue Maximum Ratio for at least three cones;
• Off-Axis Ratio for at least three cones.
5.3.1 Absolute dosimetry
Absolute dosimetry follows a code of practice or dosimetry protocol to determine the
absorbed dose in Gray at a reference depth in a water phantom. It is expressed in terms
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of number of MU per Gray for a given standard field size, source-to.skin distance (SSD)
and beam quality [22].
A dosimetry protocol provides the formalism and the data to relate a calibration of a
chamber at a standards laboratory to the measured absorbed dose to water under
reference conditions. Currently, there are two types of dosimetry protocol available: the
protocols based on air kerma in air calibration coefficients; and the protocols based on
absorbed dose to water calibration coefficients [26]. TRS-483 provides a code of
practice that rely on the absorbed dose to water, ND,W,Q0 , in a standards reference
beam of quality Q0 [24].
The equipment required for reference dosimetry depends on the LINAC reference field
size. Machines that can’t produce larger fields such as the 10x10 cm2 from a
conventional LINAC might have some restrictions on the equipment that can be used.
The limitations include smaller ionization chambers and phantoms with geometries and
materials different from those used for conventional reference dosimetry. The accuracy
required, however, is still the same [24].
A ionometric dosimeter system includes [24]:
• One or more suitable ionization chambers;
• One or more phantoms with waterproof sleeves if needed;
• An electrometer calibrated in terms of charge or current per scale division;
• One or more stability check devices, specifically designed for the chosen ionization
chamber;
• Calibrated thermometer and barometer.
5.3.1.1 Ionization chambers
Photon beams are most commonly calibrated with ionization chambers that are used as
relative dosimeters and have calibration coefficients determined either in air or in water
and are traceable to a national primary standards dosimetry laboratory (PSDL). The
traceability of a calibration coefficient to a national PSDL implies one of the following
[26]:
• The chamber was calibrated directly at the PSDL;
• The chamber was calibrated at a secondary standards dosimetry laboratory (SSDL)
or at an accredited dosimetry calibration laboratory (ADCL) that traces its calibration
to a PSDL;
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• The chamber calibration coefficient was obtained through a cross-calibration with
another ionization chamber, which as a calibration coefficient measured directly at
a PSDL, PSDL or an ADCL.
Only cylindrical ionization chambers that fulfil the specifications of a reference class
ionization chamber (table 3) are advised for absolute dosimetry in high energy photon
beams.
Table 3: Specifications for reference class ionization chambers for reference dosimetry, from Table 3 of
TRS-483.
Parameter Specification
Chamber settling Monitoring chamber response with accumulated dose:
equilibrium is reached in less than 5 minutes; the initial and
equilibrium readings agree within 0.5%.
Leakage Smaller than 0.1% of the chamber reading.
Polarity effect Smaller than 0.4% of the chamber reading. The polarity
energy dependence is less than 0.3% between 60Co and 10
MV photons.
Recombination correction 1. The correction is linear with dose per pulse.
2. Initial recombination (the dose rate or dose per pulse
independent part of the total charge recombination) is below
0.2% at polarizing voltages around 300 V.
3. For pulsed beams, a plot of 1/MQ (charge reading) vs 1/V
(polarizing voltage) is linear at least for practical values of V .
4. For continuous beams, a plot of 1/MQ vs 1/V 2 is
linear, describing the effect of general recombination. The
presence of initial recombination disturbs the linearity but this
is normally a small effect, which may be neglected.
5. The difference in the initial recombination correction
obtained with opposite polarities is less than 0.1%.
Chamber stability Change in calibration coefficient over a typical recalibration
period of 2 years below 0.3%. Same figure fr long term (> 5
years) stability.
Chamber material Wall material not exhibiting temperature and humidity effects.
5.3.1.2 Correction for influence quantities
Correction for influence quantities is required if an air-filled ionization chamber is used
in different conditions from the reference conditions. Influence quantities include the air
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density, humidity, polarization and ion recombination correction.
Air density correction
A correction is required because the mass of air in the cavity depends on temperature
and pressure. The factor kTP is given by: [24]
kTP =
(T + 273.15)× P0
(T0 + 273.15)× P (5.2)
Where T0 and P0 are the temperature and pressure for which the calibration coefficient
of the ionization chamber is valid (usually 20ºC and 1013.25 hPa). T and P are the
temperature and pressure of the air inside the cavity of the ionization chamber at the time
of measurement [24].
If the relative humidity is between the range of 20% to 80%, no correction factor is needed
for the humidity [24].
Polarity correction
Under the same irradiation conditions, using opposite polarizing potentials, the reading
should be the same. Polarity effect occurs when the reading is different. This effect is
notable in the build-up region of photon beams of low energies. When a measurable
polarity effect occurs, the true reading is taken to be the mean of the absolute values of
readings at both polarities. The polarity correction factor, kpol, is given by [26]:
kpol =
|M+|+ |M−|
2M
(5.3)
Where M+ and M− are the chamber readings obtained with positive and negative
polarities under identical irradiation conditions and M is the reading using the polarity
used routinely [26].
Ion recombination correction
The response of an ionization chamber depends on the radiation dose, dose-rate,
chamber polarity and also on the voltage applied between the measuring and collecting
electrodes of the chamber [26]. Two effects take place inside the ionization chamber
[24]:
• The recombination of ions formed by separate ionizing particle tracks (termed
general recombination) that depends on the dose rate, chamber geometry and
applied voltage;
• The recombination of ions formed by a single ionizing particle track (termed initial
recombination) that depends on the chamber geometry and applied voltage but is
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independent of the dose rate.
The correction factor ks that correct the recombination of ions because of the incomplete
collection of charge in the chamber cavity depends if the beam is continuous (like 60Co
gamma rays) or pulsed. For a common LINAC, it is given by [24]:
ks = a0 + a1 ×
(
M1
M2
)
+ a2 ×
(
M1
M2
)2
(5.4)
Where M1 and M2 are the measured values at the polarizing voltages V1 and V2. The
potential V1 is the normal operating voltage and V2 is the reduced voltage. Ideally, the
ratio V1/V2 should be higher than 3. The constants a0, a1 and a2 are the quadratic fit
coefficients that depends on the V1/V2 ratio for pulsed beams. Those constants are given
on table 4 for different V1/V2 ratios.
Table 4: Quadratic fit coefficients, for the calculation of ks by the ’two voltage’ technique used in pulsed
radiation, as a function of the voltage ratio, V1/V2.
V1/V2 a0 a1 a2
2.0 2.337 -3.636 2.299
2.5 1.474 -1.587 1.114
3.0 1.198 -0.875 0.677
3.5 1.080 -0.542 0.463
4.0 1.022 -0.363 0.341
5.0 0.975 -0.188 0.214
5.3.2 Output Factors
The radiation output increases with the collimator opening or field size and is expressed
in Gy/MU for a conventional LINAC. Typically, it is measured at a fixed point and then the
output at zmax is determined by using PDD or TMR curves. A higher depth such as 5 or
10 cm is recommended because the influence of the electron contamination is negligible
[22].
The measured output factor is assumed to be a product of two independent effects: the
phantom scatter factor (Sp) and the collimator scatter factor (Sc) [22]:
OF = Sp × Sc (5.5)
Phantom scatter factor depends on the scatter geometry within the phantom or patient
and can be modified by varying the beam shaping, SSD and the phantom or patient
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shape. Collimator scatter factor depends on the collimator settings and the presence of
additional filters [22].
The measured output is normalized to the radiation output of the calibration field size,
topically 10x10 cm2 in a conventional LINAC. Usually, they are presented graphically as
a function of equivalent square field sizes. This assumes that the output of a rectangular
field is equal to the output of the equivalent square field. If the difference between them is
more than 2%, it may be necessary to have separate tables for the output factors for each
rectangular field [26]. Since we are dealing with stereotactic cones, this is not a problem
and only a measurement for each cone is needed.
5.3.3 Tissue Maximum Ratio
TMR is defined as the ratio of the dose rate, D(d, S), on the beam central axis in the
phantom at an arbitrary depth d, to the dose at the depth of maximum dose, D(dmax, S)
[26]:
TMR(d, S) =
D(d, S)
D(dmax, S)
(5.6)
Where S is the field size.
For instance, if the measurement is normalized at a different depth (dref ), Tissue
Maximum Ratio becomes Tissue Phantom Ratio (TPR) [22].
TMR can be measured in water or solid phantoms by keeping the detector at a constant
distance from the source and varying the overlying depth of material [22]. Nowadays,
TMR are measured with a water tank that can precisely control the water drain, changing
the SSD continuously while the detector is measuring the dose rate at a fixed distance
from the radiation source.
5.3.4 Off-Axis Ratio
OAR is defined as the ratio of dose at a point away from the central axis, D(x, S), to the
dose at the point on the central axis, D(0, S), at the same depth [22]:
OAR(x, S) =
D(x, S)
D(0, S)
(5.7)
Where x is the distance away from the central axis and S is the field size.
The depths and field sizes required to be measured are demanded by the TPS that is
being commissioned. Combining central axis dose distribution (TMR) with off-axis data
29
FCUP
Development of an independent MU calculation methodology for treatments with small fields
provides 2D and 3D information of the dose distribution [26].
OAR plays an important role in the determination of the field width. The distance
between the 50% OAR values defines the field size. The geometrical field edge (defined
by the collimators) and the light field edge must coincide with these 50% points of OAR
measurements [22]. However, for small fields, due to the partial occlusion from the
source and loss of LCPE, there is a reduction of the beam output and the resulting
FWHM is not consistent with the geometrical definition of the field because the FWHM is
determined by a lower position on the penumbrae curve. Thus, the field size at 50%
relative dose becomes broader than the geometrical field size defined by the collimator
[24]. This effective is shown on figure 3 of chapter 3.1.1.
5.4 Generating TMR configuration data from measured data
CDC configuration program fits the data to this equation:
TMR(d) = A× e−u×d +B × db × e−
(
d
d1
)10
(5.8)
Where:
• d1 = 2×(dmax+10mm) = power law correction to the exponential function to improve
the continuity of the fitted function in the vicinity of dmax + 10mm;
• d = depth;
• dmax = depth of maximum dose;
• A, u,B, b = curve fitting parameters used in CDC configuration.
The parameters A and u are obtained by fitting the exponential function to the TMR data
starting from the depth dmax + 10mm. Subtracting the resulting exponential curve from
the data results in a difference curve that is used for obtaining B and b by fitting the power
law function to that difference in the interval dmax + 10mm.
Since it is not necessary to perform TMR measurements for all collimators, the data for
each missing collimator can be calculated by power law interpolation and extrapolation
from other measurements.
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5.5 Generating OAR configuration data from measured data
CDC configuration program applies a curve fit algorithm to the measured data using the
following double exponential model:
OAR(r) =
0.5 + 0.5×
(
f(r)−f(r0)
f(0)−f(r0)
)
if (r ≤ r0)
0.5×
(
g(r)−1
g(r0)−1
)
if (r > r0)
(5.9)
Where:
• r = distance from the central axis to the point where the dose is being calculated;
• r0 = collimator radius corrected for source-to-target distance;
• f(r) = (1− ea1×(r−r0))× (1− ea2×(r−2×r0))
• f(r) = (1− eb1×(r0−r))× (1− ea2×(−b2×r))
Where:
a1, a2, b1, b2 = curve fitting parameters used in CDC configuration.
Long tails of measured OAR curves are discarded. The equation above fits the data for
points which r < rcut off where rcut off = 0.75 × r0 + 0.5(cm). This approximates the spot
where OAR has dropped below 1.5%.
In the case of cone collimator fields, the shape of a rescaled OAR curve exhibits
practically no dependence on the source-to-target distance (STD). Hence, for a given
cone size, the OAR curves for all STDs can be obtained from one OAR curve by the
rescaling equation:
OAR(r, STD2) = OAR
(
STD1
STD2
× r, STD1
)
(5.10)
Before fitting the measured OAR curves, all curves are rescaled to one reference STD,
STDref . The resulting fitting parameters are interpolated by power lawn for all cone
sizes. This gives OAR curves for each cone at STDref . The OAR for any other STD can
be obtained by using the equation (5.10) again.
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6 Implementation
This work involved three major steps. The first one was data acquisition of TMR, OAR
and OF with a synthetic diamond detector for both LINACs, TrueBeam™ STx and Novalis
Tx™.
The next major step was the MATLAB® development of a graphical user interface (GUI)
for beam data import and process of the measured / golden beam data and CT calibration
curve. This application is referred as ”Beam Configuration”. Another GUI was created
to import the phantom or patient DICOM data to verify the MU of each field, with and
without heterogeneity correction, based on the data exported from the TPS and the beam
data previously processed for both LINACs. This application is called ”Stereotactic MU
Calculator” and is the main application of this project.
The last step was the verification of the GUIs. First the MATLAB® algorithm was tested
against CDC calculations in different scenarios and latter it was tested in different
phantoms using ionization chamber.
6.1 Materials
6.1.1 Linear accelerators
Two LINACs, TrueBeam™ STx and Novalis Tx™, with stereotactic cones were studied in
this work. All LINACs features were described earlier in chapter 2.2.
The energies used were the ones used clinically for treating patients. For TrueBeam™
STx only energies without flattening filter were used (6 FFF and 10 FFF). For Novalis
Tx™, a single energy was used, 6 MV with flattening filter (WFF) in SRS mode.
6.1.2 CT scan
The CT scan used for scanning phantoms and patients was the GE LightSpeed RT 16
from GE Healthcare. The CT calibration curve used was the one that is used for Eclipse™
TPS of IPO Porto at the time of this work.
6.1.3 Detectors and equipment
Absolute dosimetry
A PTW Farmer 30013 (figure 6a) was used for absolute dose measurements of both
LINACs, for WFF and FFF energies. This ionization chamber is intended for absolute
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dosimetry with a sensitive volume of 0.600 cm3. The chamber has a thimble wall made
of 0.09 mm mm thick graphite layer protected by a 0.335 mm acrylic exterior wall. This
combination makes the chamber air-equivalent [35].
A PTW UNIDOS E (figure 6b) electrometer was used to read the electric charge
accumulated by the ionization chamber. The water tank used was a PTW MP3 with
lifting capabilities.
(a) PTW Farmer 30013 (b) PTW UNIDOS E
Figure 6: Ionization chamber and electrometer used for absolute dosimetry. Images from PTW Freiburg
GmbH.
Relative beam data acquisition
For TMR, OAR and OF measurements a PTW microDiamond 60019 (figure 8a) was
used. This is a synthetic diamond detector nearly water equivalent for all beam energies,
it has a very small sensitive volume (0.004 mm3 with 4 mm2 of active measurement area
and 0.001 mm thickness, suitable for all field sizes up to 40x40 cm2 [36]. This detector is
well known for having a high linearity, low angular and negligible dose rate dependence
[28]. It needs correction factors below field sizes below 10 mm, since the correction factor
is higher than 1% in that range. At very small field sizes the combination of volume
averaging and detector material perturbation effects compensate each other leading to
low overall output correction factors [37]. The OF correction factors used were the ones
described in the TRS-483.
When compared to other detectors used in small field dosimetry, PTW microDiamond
60019 shows a very small deviation of absorbed dose to water starting from 5x5 mm2
square field sizes [36] as shown in the below figure:
Figure 7: PTW microDiamond response shift compared to others detectors in the market. Image adapted
from PTW Freiburg GmbH.
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The electrometer used for TMR and OAR was a PTW Tandem (figure 8b) and for OF a
PTW UNIDOS E was used (the same for absolute dose measurement).
(a) PTW microDiamond (b) PTW Tandem
Figure 8: Detector used for relative measurements and electrometer used for TMR / OAR. Images from PTW
Freiburg GmbH.
The same water phantom system, shown in figure 9, was used for absolute dosimetry
and relative measurements.
Figure 9: PTW MP3 water tank system used for absolute and relative dosimetry. Image from PTW Freiburg
GmbH.
FWHM film measurements
GAFChromic™ EBT3 films (figure 10a) were used to confirm the FWHM diameter of
each cone. The film is composed by an active layer with 28 µm thick and a
matte-polyester substrate of 125 µm thick on both sides. The active layer contains a
marker dye - which is the active component - and stabilizers among other components
that give the radiochromic film its near energy independent characteristic [38]. These
radiochromic films have a dynamic dose range from 0.1 Gy to 20 Gy however the
optimum interval is from 0.2 Gy to 10 Gy. It also features a symmetrical construction and
a anti-Newton ring coating while the previous model (EBT2) did not support [39].
A flatbed scanner Epson Expression 10000XL was used to scan all the films and convert
them to digital image, as observed in figure 10b.
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(a) GAFChromic™ EBT3 films. (b) Epson Expression 10000XL scanner.
Figure 10: Radiochromic films and scanner used for cone FWHM confirmation. Images from GAFChromic
and Epson product page respectively.
In phantom absolute dose verification
A PTW PinPoint 3D 31016 (figure 11) was used for absolute dose verification in
phantoms. It is a small cylindrical ion chamber with 0.016 cm3 (1.45 mm radius and
2.9 mm length). It has a small polarity effect, small directional response, short ion
collection time and a low pre-irradiation dose is required. It is suitable for IMRT,
stereotactic beams and can be used also for large fields up to 40x40 cm2 [40]. OF
correction factors from TRS-483 were applied. Due to the field size and the detector
size, TRS-483 only includes correction factors below ± 5%. Values outside this interval
are excluded and extrapolation is to be avoided. For this reason, dose verification was
performed only for cones with a nominal size equal or above 10 mm.
Figure 11: PTW PinPoint 3D 31016. Image from PTW Freiburg GmbH.
Two phantoms were used to test the algorithms developed. Lucy® 3D QA phantom
(figure 12a) from Standard Imaging in a first step was used to verify the dose in the ion
chamber positioned at the isocenter. Due to it’s almost homogeneity, it was used to
verify the algorithms created without heterogeneity correction. Later, in order to verify
the heterogeneity correction algorithm, a QUASAR™ thorax phantom (figure 12b) from
Modus QA was used. This phantom has cylindrical inserts to simulate lungs, bones and
others densities.
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(a) Standard Imaging Lucy® 3D QA phantom. (b) Modus QA QUASAR™ thorax phantom.
Figure 12: Phantoms used for in phantom absolute dose verification. Images from Standard Imaging and
Modus QA product page respectively.
6.1.4 Software
Varian Golden Beam Data
Some beam data provided by Varian was used in this work. This is a pre-configured
beam data that customers can use in TPS commissioning. It is distributed in w2CAD
format or in an Excel spreadsheet. It can be compared to the user measurements and
imported and calibrated into the Eclipse™ system.
A w2CAD file (.asc) must contain the measurements in a specific table format and must
be saved into a ASCII file.
PTW MEPHYSTO mc2
Measurements in the water phantom were made using the PTW MEPHYSTO mc2 suite
software and were exported in its proprietary file format.
A mc2 file (.mcc) it’s saved in plain text which means that can be opened and edited
without any proprietary software. Each file can contain single or multiple measurements
from different measurement types (PDD, TMR or OAR mostly). There is a header for each
measurement that contains dozens of data associated with the measurement itself, such
as date, measurement type, ionization chamber used, machine, beam characteristics
(such as field size, energy) and setup conditions.
Data is saved in a discretized way for each detector position inside the water phantom.
The detector position (in x, y or z axis depending on the measurement) and the
accumulated charge during a user pre-defined time interval are saved to the
MEPHYSTO mc2 file.
CDC planning system and DICOM format
All the plans for phantoms or patients were created in CDC treatment planning system
and were exported in the Eclipse™ workspace in DICOM format (.dcm).
DICOM is a communication protocol and file format. Every DICOM file can store medical
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information, image(s) and patient information. The format ensures that DICOM files can
be exchanged between two entities or machines that support the DICOM standards [41].
DICOM-RT is an extension of the DICOM protocol that was created to set the standard
for data integration and communication between different equipment manufacturers and
radiation therapy equipment [42]. There are seven DICOM-RT objects: RT Image, RT
Structure Set, RT Plan, RT Dose, RT Beams Treatment Record, RT Brachy Treatment
Record, RT Treatment Summary Record, RT Ion Plan and RT Ion Beams [42]. In fact,
only three objects are in the scope of this work: RT Structure Set, RT Plan and RT Dose:
• RT Structure Set: defines a set of areas of significance such as target volumes,
organ at risk, external contour or other regions of interest. It also defines the
regions of interest (ROI) type and its physical properties such as the relative
electron density;
• RT Plan: contains every geometric and dosimetric data of the treatment, including
the position of the patient, the treatment technique, fractionation scheme, reference
points and individual beam characteristics (isocenter, gantry, collimator and couch
angles, field size, beam modifiers and accessories used, tolerance table, number
of MU, control points, among others);
• RT Dose: contains planar (2D) or volumetric (3D) dose generated by the TPS. It
also includes the dose-volume histogram (DVH) and dose statistics.
To satisfy the purpose of this work, only these DICOM-RT objects are required plus the
CT scan that is exported also in DICOM format.
MATLAB® developed algorithms
All the algorithms developed during this work were created in MATLAB® R2019a from
MathWorks. MATLAB® is a high-level programming language for technical computing. It
allows matrix manipulations, function plotting, algorithm implementation, creation of user
interfaces and interfacing with other programming languages.
Graphic interfaces were designed and programmed in App Designer and then compiled
to a stand-alone executable application that runs on Windows, Linux or macOS.
Variables that are transversal to multiple scripts or GUIs were saved as a MAT-file. MAT-
files are binary MATLAB® files that store workspace variables that can be opened, edited
and saved again, if desired.
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6.2 Methods
6.2.1 Absolute dosimetry
TRS-483 states that reference dosimetry of LINACs where a conventional 10x10 cm2 can
be established should follow TRS-398 protocol.
The reference conditions to determine the absorbed dose to water are the following [43]:
• SCD: 100.0 cm
• Depth: 5 cm if TPR20,10 < 0.7 or 10 cm if TPR20,10 ≥ 0.7
• Field size: 10x10 cm2
• Energy: 6 FFF and 10 FFF for TrueBeam™ STx and 6X SRS for Novalis Tx™
A SSD of 95 cm with a depth of 5 cm was chosen because it was recommended by the
Eclipse Photon and Electron Algorithms Reference Guide [34].
The dose rate of the absolute dosimetry measurements was the same used clinically for
radiosurgery treatments: 1400 MU/min for 6 FFF, 1200 MU/min for 10 FFF and 1000
MU/min for 6X SRS.
The absorbed dose to water at the reference depth zref in water, in a photon beam of
quality and in the absence of the chamber, is:
Dw,Q = MQ ×ND,w,Q0 × kQ,Q0 (6.1)
Where MQ is the dosimeter reading corrected for the influence quantities, ND,w,Q0 is the
calibration factor in terms of absorbed dose to water for the dosimetry at the reference
qualityQ0 and kQ,Q0 is a chamber specific factor which corrects for the difference between
the reference beam quality Q0 and the actual quality used, Q.
If the reference quality Q0 is 60Co, ND,w,Q0 is denoted by ND,w and kQ,Q0 is denoted by
kQ.
6.2.2 Relative beam data acquisition
All the required measurements for CDC algorithm configuration [34] were performed
using the TRS-483 code of practice [24] for relative dosimetry of small fields used in
radiotherapy.
The same measurements setup were used for TrueBeam™ STx and Novalis Tx™ LINAC.
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As previously stated, a PTW MP3 water tank and a PTW microDiamond 60019 detector
were used for the relative beam data acquisition.
The major axis of the detector was aligned parallel with respect to the beam central axis,
as recommended by the code of practice, as observed in figure 13 [24].
Figure 13: Detector orientation used in relative beam data acquisition. Image adapted from TRS-483.
Another factor that is transversal to all measurements is the jaw size. A square field of 5x5
cm2 in TrueBeam™ STx and 2x2 cm2 in Novalis Tx™ was defined for all measurements,
to match the jaw size of the reference field.
To ensure that the beam is parallel to the vertical axis of the water tank, a center check
was performed at two different depths every time a cone was inserted into the LINAC.
No reference ionization chamber was used in OAR and TMR measurements due to the
small cone sizes. To minimize the noise of the curves, the acquisition time and the delay
time between each measurement was increased and the detector moving speed was
decreased.
The dose rate of the relative dosimetry measurements was the same used clinically for
radiosurgery treatments: 1400 MU/min for 6 FFF, 1200 MU/min for 10 FFF and 1000
MU/min for 6X SRS.
Output Factors
Accordingly to TRS-483, output factors relate the absorbed dose to water of a clinical
field fclin to the reference field, fref . They are derived from the measured ratio of
detectors readings multiplied by an adequate correction that converts the ratio of
measured readings into a ratio of values of absorbed dose to water.
The field output factor, Ωfclin,frefQclin,Qref is defined by:
Ω
fclin,fref
Qclin,Qref
=
MfclinQclin
M
fref
Qref
× kfclin,frefQclin,Qref (6.2)
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Where MfclinQclin and M
fref
Qref
are the readings of the detector in the clinical and reference
field, respectively. The readings should already be corrected by the influence quantities.
Output factors readings were performed in the same setup conditions as the reference
field:
• SSD: 95.0 cm
• Depth: 5.0 cm
• Monitor Units: 100 MU
• Cones: 4, 5, 7.5, 10, 12.5, 15 and 17.5 mm for TrueBeam™ STx and 4, 6, 7.5, 10,
12.5 and 15 mm for Novalis Tx™
• Energy: 6 FFF and 10 FFF for TrueBeam™ STx and 6X SRS for Novalis Tx™
Figure 14: OF scheme.
To apply the field output factor correction, kfclin,frefQclin,Qref , the equivalent square field size of
each cone as to be determined using the equation:
Sclin = r ×
√
pi (6.3)
Where r is half of the FWHM diameter of the cone.
TRS-483 has several output correction factors depending on the machine, energy and
detector used. It is worth to mention that the minimum field size recommended for
measurements is such that the detector specific output correction factor is not greater
that ±5% for a particular machine. For this reason, TRS-483 does not include kfclin,frefQclin,Qref
values outside this interval.
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For PTW microDiamond 60019 detector, there are correction factors available up to 4x4
mm2 square fields. This is a problem because the smallest cone of both LINACs has
a nominal diameter of 4 mm what means that its equivalent square field size is around
3.54x3.54 mm2 and the last correction factor available is for the 4x4 mm2 square field. To
overcome this, extrapolation was used for the smallest cone.
Field output correction factors for PTW microDiamond 60019 were fitted into a two term
exponential curve:
k
fclin,fref
Qclin,Qref
(s) = a · eb·s + c · ed·s (6.4)
Where s is the equivalent square field size and a, b, c, d are the parameters to be fitted.
Tissue Maximum Ratio
TMR is the ratio of absorbed dose at any depth along the beam axis to the absorbed
dose at depth of maximum dose. During the measurement, the STD should be fixed. The
build-up depth is defined by changing the water level of the tank.
Setup used for TMR measurements:
• STD: 100.0 cm (constant)
• Depth: From surface up to 20 cm
• Cones: At least 3 cones for each LINAC
• Energy: 6 FFF and 10 FFF for TrueBeam™ STx and 6X SRS for Novalis Tx™
Off-Axis Ratio
OAR is the ratio of absorbed dose at any point to the absorbed dose on the beam axis at
the same depth.
Setup used for OAR measurements:
• STD: 100.0 cm
• Depth: 5.0 cm
• Cones: 4, 5, 7.5, 10, 12.5, 15 and 17.5 mm for TrueBeam™ STx and 4, 6, 7.5, 10,
12.5 and 15 mm for Novalis Tx™
• Energy: 6 FFF and 10 FFF for TrueBeam™ STx and 6X SRS for Novalis Tx™
6.2.3 FWHM film measurements
Calibration curve
42
FCUP
Development of an independent MU calculation methodology for treatments with small fields
An EBT3 film calibration curve was acquired in the TrueBeam™ STx LINAC for 6 FFF
energy. The MU and the corresponding expected dose to the film are given on table 5.
The film scan was performed 24 hours posteriorly to the irradiation in an Epson
Expression 10000XL with a resolution of 72 dpi and 48 bit color depth (16 bits for each
colour channel) without any image enhance. The same settings were used in the film
acquisition of each cone.
Table 5: Number of MU and the expected absorbed dose by the films, in the central region of the beam
(CAX).
MU Expected Dose (Gy) MU Expected Dose (Gy)
0 0.000 800 6.754
50 0.422 1000 8.443
100 0.844 1500 12.665
200 1.689 2000 16.886
400 3.377 2500 21.108
The films irradiated were scanned and saved in tagged image file format (TIFF), since this
is a lossless format. An algorithm was developed in MATLAB® to create the calibration
curve and analyze the images.
To create the calibration curve, a MATLAB® script reads the image and returns the mean
pixel value (MPV) of a central area in the image with 50x50 pixels2 area. This area is
approximately 1.66x1.66 cm2 if we consider the resolution used (72 dpi). It is important
to analyse a small central area of the image because TrueBeam™ STx is a FFF
machine and the dose outside the central region of the beam decreases faster than a
WFF machine like Novalis Tx™, as shown in the beam profiles of the next figure:
Figure 15: Off-axis profile of a FFF (blue) and WFF (red) beam. Image adapted from Varian TrueBeam: The
UAB experience (Richard Popple, 2013).
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Only the red channel was used because it is the ideal channel for the dose ranges used
to measure the FWHM cone diameter [44]. Calibration curve goes up to 21.108 Gy but
the absorbed dose by the radiochromic films in the FWHM cone diameter measurement
was lower than 10 Gy. The red channel is the channel that has the highest sensitivity
for low doses. This can be demonstrated computing the first derivative of each colour
channel in the calibration curve, as shown in figure 16.
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Figure 16: First derivative of EBT3 calibration curve for all colour channels.
The mean pixel value (MPV) of the red channel of each image, including the background
film that has no exposure, are then used to return the netOD for each film with the
equation:
netOD = −log10 ×
(
Pixel MPV
Background Pixel MPV
)
(6.5)
Where Background Pixel MPV is the MPV of the unexposed film.
The obtained netOD values are then fitted in a 4th polynomial degree to create the
calibration curve.
Dose (Gy) = a× netOD4 + b× netOD3 + c× netOD2 + d× netOD (6.6)
The function coefficients a, b, c and d were found with the help of the MATLAB® Curve
Fitting Toolbox.
Finally, the script saves a curve fit object containing the polynomial model and the
coefficients of each colour channel in a MATLAB® MAT-File.
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Film irradiation and analysis
As described earlier in the chapter of Physics of small fields (chapter 3.1), if the radius
of the field is smaller than rLCPE , the penumbra of the field overlaps with the detector,
resulting in machine output reduction. This causes an increase in the FWHM measured
by the detector, exceeding the collimator aperture projected at the isocenter. To confirm
the FWHM measured with the PTW microDiamond, film irradiation was performed in the
TrueBeam™ STx for 6 FFF energy.
Films were placed between water solid slabs (PTW RW3) at the isocenter with 5 cm of
build-up (5 slabs). To provide back-scatter, a total of 10 slabs were placed below the
films. Every film was irradiated with 1000 MU and scanned 24 hours after the irradiation,
in the same orientation as the calibration curve.
FWHM of each cone through film irradiation was obtained in a developed MATLAB®
script. The script does the following:
1. Imports the calibration curve that was saved previously in a MAT-File.
2. Imports the background and irradiated scanned films and selects only the red
channel.
3. Assigns a netOD value of each pixel of the irradiated image using the equation:
netOD = −log10 ×
(
Pixel Value
Background Pixel MPV
)
(6.7)
4. Converts each pixel of the image to absolute dose with equation (6.6).
5. Creates a binary image of the red channel. The threshold used is 50% of maximum
dose. The resulting binary image should have only with 2 regions: the region with
≥ 50% of maximum dose and the region with < 50% of maximum dose.
(a) 48-bit colour image (b) 16-bit greyscale image (c) 1-bit monochrome image
Figure 17: Example of a EBT3 film scan of a single cone containing all channels (a); only the red channel
(b); and the resulting binary image (c) containing two regions: the region equal or above 50% of maximum
dose (white) and the region below 50% of maximum dose (black).
6. Retrieves the diameter of the region that contains the irradiated area with ≥ 50% of
maximum dose. The diameter is calculated based on the region area:
Diameter (pixels) =
√
4× Area (pixels
2)
pi
(6.8)
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7. The diameter is then converted from pixels to mm based on the image resolution:
Diameter (mm) = Diameter (pixels)× 25.4 (mm/inch)
Image Resolution (pixels/inch)
(6.9)
Since the image resolution is always the same, 72 pixels per inch, the equation
(6.9) is reduced to:
Diameter (mm) = Diameter (pixels)× 0.3527(7)
(
mm
pixels
)
(6.10)
The diameter obtained with the above equation is the cone FWHM.
Step 3 to 7 are repeated for each irradiated film.
6.2.4 Beam Configuration application
”Beam Configuration” was created to store reference conditions and absolute dose
calibration of each LINAC and energy; import, visualize and process beam data
acquired from measurements or golden beam data provided by Varian; and import the
CT calibration curve of the CT scanner. Two ”Beam Configuration” applications were
built, one for TrueBeam™ STx and another for Novalis Tx™.
The goal of this application is to save a MAT-File with all above data to later be used in the
’”Stereotactic MU Calculator”. Every time a change is made in CDC algorithm that affects
beam data, absolute dose calibration or CT calibration curve, a new MAT-File should be
created with the new data.
The application has 5 main tabs:
• Parameters tab: machine parameters, reference conditions and absolute dose
calibration.
• TMR: to import, visualize and process TMR from measurements / Varian golden
beam data.
• OAR: to import, visualize and process OAR from measurements / Varian golden
beam data.
• OF: to import output factors values and visualize the curve generated.
• CT calibration: to import CT calibration curve values (housfield units (HU) and the
corresponding relative electron density (RED)).
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6.2.4.1 Parameters
Parameters tab is the first tab to be filled before the beam data import. It contains specific
values that are important for beam data processing. There are a total of six textbox
groups including one for comments. Some textboxes have predefined values that need
to be confirmed by the user.
Figure 18: Beam Configuration application - Parameters tab overview.
Machine Constants
Source-axis distance (SAD) is the only constant that needs to be filled. It is 1000 mm for
conventional radiotherapy LINACs and it will not change for TrueBeam™ STx or Novalis
Tx™. However, the variable is not hard-coded in the software source-code because in
the future this application might be used in non-conventional LINACs where SAD is not
1000 mm.
Table 6: Parameters Tab - Machine Constants.
Description Default Value Unit
Source-axis distance 1000 mm
47
FCUP
Development of an independent MU calculation methodology for treatments with small fields
Reference Conditions
Reference conditions used in absolute dosimetry such as field size, source to phantom
distance, calibration depth, dose at calibration depth and MU at calibration depth are
required.
Default values of reference field size, source to phantom distance and calibration depth
are the same used for TrueBeam™ STx and Novalis Tx™ calibration at the time of this
work.
Table 7: Parameters Tab - Reference Conditions.
Description Default Value Unit
Absolute dose reference field size 100 mm
Absolute dose calibration source-phantom distance 950 mm
Absolute dose calibration depth 50 mm
Reference dose at calibration depth 0 Gy
Reference MU at calibration depth 0 MU
Energy
Energy currently being configured can be changed in a drop-down menu and depends
on the LINAC. For TrueBeam™ STx 6 FFF and 10 FFF are available. For Novalis, only
6X SRS MV is available. There is a textbox with the depth of maximum dose that is
automatically calculated based on the energy chosen. For 6 FFF or 6X SRS MV it is 15
mm and for 10 FFF is 25 mm.
Table 8: Parameters Tab - Energy.
Description Value(s) Unit
Energy 6 or 10 MV
Depth of maximum dose 15 or 25 mm
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OAR settings for Varian golden data and Mephysto data
There are two groups of textboxes where the user can select the SSD and depth
accepted from OAR measurements. One textbox is for Varian golden data and another
is for Mephysto data. This was introduced because some OAR data files may include
multiple measurements at different SSDs/depths and only one SSD and depth is
required.
Additionally, there is a textbox where the user can select a new SSD if the measurement
was taken at a different SSD from the planned. The computation of new OAR
measurements at a different SSD is only a geometric change and uses the equation
(5.10).
Table 9: Parameters Tab - OAR Settings (Golden Data).
Description Default Value Unit
SSD accepted 1000 mm
Depth accepted 50 mm
Rescale SSD to 950 mm
Table 10: Parameters Tab - OAR Settings (Mephysto Data).
Description Default Value Unit
SSD accepted 950 mm
Depth accepted 50 mm
Rescale SSD to 950 mm
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6.2.4.2 TMR
TMR tab allows importing TMR from Varian golden beam data in its proprietary w2CAD
file format or from measurements saved in a Mephysto mc2 file. The user can apply linear
or exponential curve fitting and can visualize graphically the TMR data points measured
and the interpolated curve.
Importing Varian golden beam data for Novalis Tx™ is disabled because Varian does not
provide golden data for Brainlab stereotactic cones.
Figure 19: Beam Configuration application - TMR tab overview.
Varian golden beam data import
Only ASCII files with .asc extension that follows w2CAD file format are accepted by the
application. The user must verify that all measurements being imported are from the
correct energy. TMR from all cones should be imported and none can be duplicated.
Import of single and multiple files is supported.
The application will check some parameters in the file header in order to verify if the data
being imported was correctly acquired. These parameters, also known as flags, are
read from the available data. Each flag stores a parameter such as the beam type,
measurement type, measurement axis, field size and other important parameters
depending if the beam data is OAR or TMR.
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The following parameters are checked while importing TMR from Varian golden beam
data files:
Table 11: Varian golden beam data required flags for TMR measurements
Flag Name Description Accepted Value
BMTY Beam Type PHO
TYPE Measurement Type TMR
AXIS Measurement Axis Z
FLSZ Field Size Valid nominal cone size
If one of the flags has another value from the accepted, import beam data skips the
current measurement being read and continues to the next one, if available.
Mephysto beam data import
The application accepts Mephysto mc2 files saved with .mcc extension. The user must
verify if is importing the measurement for the energy chosen. Only 3 measurements from
different cones are required. The remaining ones are obtained through interpolation and
extrapolation. As with Varian golden beam data import, single or multiple files can be
imported at the same time and there no can be measurements repeated for the same
cone.
The following parameters are checked while importing TMR from Mephysto beam data:
Table 12: Mephysto beam data required flags for TMR measurements
Flag Name Description Accepted Value
SCAN CURVETYPE Measurement Type TPRCURVE
FIELD INPLANE Field size inplane Valid nominal cone size
FIELD CROSSPLANE Field size crossplane Valid nominal cone size
Flag FIELD INPLANE should be equal to FIELD CROSSPLANE. If the measurement
found is not a TPR curve or if the field size in crossplane or inplane is not the same, the
import beam data skips the current measurement being read and continues to the next
one, if available.
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Beam data processing
Raw data imported from Varian golden beam data or from Mephysto data are interpolated
to 1.0 mm spacing. A linear or exponential curve fit is applied, depending on the user
choice.
The following interpolation methods are available:
• Linear
• Linear + Smooth
• Exponential
Linear
In linear interpolation data is interpolated to 1.0 mm spacing between measurements and
no more processing is applied. It is recommended to be used in already smoothed curves
such as measurements imported from Varian golden beam data.
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Figure 20: TMR curve of a measurement taken from Varian golden beam data with a measurement spacing
of 5.0 mm (black dots) and the interpolated curve with 1.0 mm spacing (blue line).
52
FCUP
Development of an independent MU calculation methodology for treatments with small fields
Linear + Smooth
Linear + Smooth interpolation method interpolates measurements to 1.0 mm spacing and
smooths the curve with a local regression method using weighted linear least squares and
a 2nd degree polynomial model. It is recommended to be used in noisy TMR curves that
have been acquired without a reference detector and have not been smoothed yet.
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Figure 21: TMR curve of a measurement taken from Mephysto data without smoothing.
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Figure 22: TMR curve of a measurement taken from Mephysto data with smoothing.
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Exponential
Exponential curve fit applies a two-term exponential model to the measured values. It
is useful to eliminate all the noise from TMR curves. Output curves using this method
are smoother than the method explained above because the decay past the depth of
maximum dose is exponential.
The model applied is the following:
TMR(depth) = a · eb·depth + c · ed·depth (6.11)
Coefficients a, b, c and d are automatically determined based on the TMR measurement
being interpolated.
After the coefficients determination, a new TMR curve of 1.0 mm spacing between
measurements is generated.
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Figure 23: TMR curve of measurement taken from Mephysto data (black dots) with a exponential curve fit
applied (blue line).
Once the curve fitting method is applied, TMR curves for missing cones are generated.
This is only valid from measurements taken from Mephysto data because all
measurements from Varian golden beam data should be imported.
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Generating a TMR curve for a missing cone is done with interpolation and extrapolation.
For each depth, TMR values of measured cones are fitted into a two-term exponential
model and the coefficients are determined. TMR values for missing cones are then
generated with a equation similar to equation (6.11):
TMR(S) = a · eb·S + c · ed·S (6.12)
Where S is the nominal cone size and a, b, c and d are the curve coefficients.
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Figure 24: TMR values in function of nominal cone size for a depth past the depth of maximum dose.
Measured TMR values are displayed as black dots and the interpolated TMR values for missing collimators
are displayed as red dots. The exponential curve (blue line) was generated from measured TMR values
(displayed as black dots).
In order to increase the accuracy, TMR for the smallest and largest cone should be
provided. This way, only interpolation is required to generate TMR curves for missing
collimators and no extrapolation is made. User should keep in mind that extrapolation of
TMR curves for the smallest or largest cone might lead to a less accurate generated
TMR curve because the fit model applied is valid only on the range of the cones used.
Loss of accuracy can occur because extrapolation of the smallest or the largest cone
using data from intermediate cones is a prediction from the model.
In the end of TMR data processing, the application ensures that TMR curves are
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normalized to the depth of maximum dose (dmax) chosen in Parameters tab:
TMR(d, S) =
D(d, S)
D(dmax, S)
(6.13)
Where S is the nominal cone size, D(d, S) is the TMR value at depth d and D(dmax, S) is
the TMR value at the depth of maximum dose.
6.2.4.3 OAR
OAR tab allows importing OAR from Varian golden beam data in its proprietary w2CAD
file format or from measurements saved in a Mephysto mc2 file. The user can visualize
graphically the OAR data points measured and the interpolated curve. Unlike TMR beam
data import, the user can’t apply a curve fit to OAR imported data. All measurements are
interpolated linearly.
Importing Varian golden beam data for Novalis Tx™ is disabled because Varian does not
provide golden data for Brainlab stereotactic cones.
Figure 25: Beam Configuration application - OAR tab overview.
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Varian golden beam data import
Only files with .asc extension that follows w2CAD file format are accepted by the
application. The user must verify that all measurements being imported are from the
correct energy. OAR from all cones should be provided and none can be duplicated.
Import of single and multiple files is supported.
The application will check some parameters in the file header in order to verify if the data
being imported was correctly acquired.
Table 13: Varian golden beam data required flags for OAR measurements
Flag Name Description Accepted Value
BMTY Beam Type PHO
TYPE Measurement Type OPP
AXIS Measurement Axis X or Y
FLSZ Field Size Valid nominal cone size
SSD SSD Same chosen in Parameters tab
DPTH Depth Same chosen in Parameters tab
If one of the flags has another value from the accepted, import beam data skips the
current measurement being read and continues to the next one, if available.
Mephysto beam data import
The application accepts Mephysto mc2 files saved with .mcc extension. The user must
verify if is importing the measurement for the energy chosen. Measurements from all
cones are required. As with Varian golden beam data import, single or multiple files can
be imported at the same time and there no can be measurements repeated for the same
cone.
The following parameters are checked while importing beam data:
Table 14: Mephysto beam data required flags for OAR measurements
Flag Name Description Accepted Value
SCAN CURVETYPE Measurement Type INPLANE PROFILE or
CROSSPLANE PROFILE
FIELD INPLANE Field size inplane Valid nominal cone size
FIELD CROSSPLANE Field size crossplane Valid nominal cone size
Flag FIELD INPLANE should be equal to FIELD CROSSPLANE. If the measurement
found is not a OAR curve or if the field size in crossplane or inplane is not the same, the
import beam data skips the current measurement being read and continues to the next
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one, if available.
Beam data processing
Raw data imported from Varian golden beam data or from Mephysto data have different
processing. Golden beam data is less processed because it already comes with a equal
spacing between measurement points and profiles comes cut in half. Averaging both
sides of profiles and cut in half is a common technique in profiles acquired with
stereotactic cones because profiles are assumed to be symmetrical on both sides.
Varian golden beam data processing
Varian golden beam data for Varian stereotactic cones is presented in 3 different SSDs
(800, 900 and 1000 mm) and one depth (50 mm). User can choose the SSD to be
imported in the Parameters tab. Profiles are recommended to be rescaled to a SSD of
950 mm because this SSD ensures that the measurement is taken at 1000 mm from the
source (the distance at which the field size is defined). However, the user can choose a
different SSD in the Parameters tab, if desired.
Profile rescaling is made as following:
OAR(r, SSD2) = OAR
(
SSD1
SSD2
× r, SSD1
)
(6.14)
Where r is the radial distance from CAX, SSD1 is the SSD from the measurement and
SSD2 is the new SSD.
Mephysto data processing
OAR curves from Mephysto data files requires more processing if OAR profiles are
acquired without any post-processing in Mephysto software. Mephysto allows to space
measurement points equally and allows to average negative and positive sides of beam
profiles. However, the developed application ensures that OAR profiles are correctly
processed if it was not done previously in Mephysto software.
OAR measurements from Mephysto data are interpolated to a 0.25 mm spacing because
using an equal spacing facilitates the next post-processing steps. Spacing distance of
measurement data points should be low enough to not compromise the shape of the
beam profile, especially in the penumbra region. The smallest the spacing distance of
the measurements, the better the penumbra definition.
The next step is the removal of the negative side of beam profiles. To cut the beam profile
in half, the negative side is averaged with the positive side:
OAR =
OAR− +OAR+
2
(6.15)
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Where OAR− and OAR+ are the negative and positive OAR measurement values of the
beam profile, respectively. This is applied to both crossplane and inplane profiles, if they
were imported. Then they are averaged:
OAR =
OARinplane +OARcrossplane
2
(6.16)
The resulting beam profile is then rescaled to a different SSD, if it was chosen in
Parameters tab, using equation (6.14).
Final data processing
Finally, all measurements from Varian golden beam data or from Mephysto data are
interpolated linearly with a 0.1 mm spacing and normalized to the central axis (CAX):
OAR(x, S) =
D(x, S)
D(0, S)
(6.17)
Where x is the distance away from the central axis, S is the field size, D(x, S) is the OAR
value at a point away from the CAX and D(0, S) is the OAR value at CAX.
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6.2.4.4 OF
OF tab allows introducing OF values for the current LINAC and energy being configured.
Field output corretion factors should be applied to the data introduced. A two-term
exponential curve fit is applied to the data. The user can visualize graphically the OF
values introduced and the interpolated curve.
Figure 26: Beam Configuration application - OF tab overview.
Model applied:
OF (S) = a · eb·S + c · ed·S (6.18)
S is the field size and a, b, c and d are the parameters to be fitted.
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6.2.4.5 CT calibration
CT calibration tab allows introducing CT calibration curve data. A set of different
Hounsfield units and the corresponding relative electron density are required. There is
no need to introduce the mass density calibration curve.
RED is stored as a function of HU. To create a curve, data is interpolated linearly.
Figure 27: Beam Configuration application - CT Calibration tab overview.
6.2.4.6 Data management
”Beam Configuration” application for TrueBeam™ STx and Novalis Tx™ stores all the
values introduced and imported by the user and also stores the generated curves for
TMR, OAR, OF and CT calibration curve with proper interpolation in a single MAT-File
with .mat extension. A MAT-File should be created for each LINAC and energy configured.
If multiple CT scanners are used with different calibration curves, this procedure should
be repeated for each CT scan. It is possible to load a saved file, edit values and save it
again.
MAT-Files are used in the ”Stereotactic MU Calculator” application. Each MAT-File
contains all the required beam data such as absolute dose calibration parameters and
relative measurements (TMR, OAR, OF) that are necessary to calculate the dose in a
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phantom or patient. Explanation of how the ”Stereotactic MU Calculator” works will be
given in the next chapters.
6.2.5 Stereotactic MU Calculator application
”Stereotactic MU Calculator” is the main application of this project. It is a GUI that allows
importing DICOM data from phantoms or patients. It uses beam data previously
processed in ”Beam Configuration” application in order to verify the number of MU of
each treatment field. It supports exported plans from Eclipse™ workspace planned for
TrueBeam™ STx (6 FFF and 10 FFF) and Novalis Tx™ (6X SRS) using stereotactic
cones.
Figure 28: Stereotactic MU Calculator application overview.
A folder should be created for each treatment plan with all DICOM data. Sub-folders
can be created to organize files. The application will recursively read all files with .dcm
extension inside the folder selected by the user. Multiple DICOM data from different plans
cannot be mixed in the same folder because only a single plan can be loaded at the same
time.
The following files are required:
• CT images
• DICOM RT Structure Set
• DICOM RT Plan
• DICOM RT Dose
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The imported plan must be previously approved in Eclipse™ workspace with a ”Planning
Approved” or ”Treatment Approved” status. It must be prescribed and calculated with a
3D dose volume. A valid collimator must be assigned to every treatment field
(setup-fields are discarded). Only plans with static fields or arc fields are supported.
These verifications are performed automatically by the application while importing and
processing the DICOM data files.
DICOM files are filtered depending on its Modality attribute on the file metadata. The
application will import the following DICOM objects:
Table 15: DICOM objects supported.
DICOM object Modality attribute SOP UID
CT images CT 1.2.840.10008.5.1.4.1.1.2
RT Structure Set RTSTRUCT 1.2.840.10008.5.1.4.1.1.481.3
RT Plan RTPLAN 1.2.840.10008.5.1.4.1.1.481.5
RT Dose RTDOSE 1.2.840.10008.5.1.4.1.1.481.2
6.2.5.1 DICOM Coordinates System
Before going on to the CT images and DICOM RT objects imported it should be defined
what is the DICOM Coordinates System.
DICOM Reference Coordinates System (RCS) or DICOM patient-based coordinate
system defines the location of the image with respect to the body of the patient. It is
based on X, Y and Z axis. X axis is the sagittal plane and separates the left from the
right; Y axis is the coronal plane, perpendicular to the ground and separates the front
(anterior) from the back (posterior); Z axis is the axial plane, parallel to the ground and
separates the head (superior) from the feet (inferior).
Figure 29: Coordinates systems in a MRI scanner. The same is valid for a CT scanner. Image downloaded
from https://www.slicer.org/wiki/Coordinate systems.
The origin is the intersection of all three mutually perpendicular axes. The origin is defined
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in the CT scanner and is stored in the Image Position (Patient) attribute. It contains the
x, y and z coordinates of the upper left corner (center of the first voxel transmitted) of the
image, in mm [45].
LPS (left, posterior, superior) is the default DICOM orientation:
LPS =

X axis from right of the patient towards left
Y axis from anterior of the patient towards posterior
Z axis from inferior of the patient towards superior

DICOM 2D images are stored row by row, from the left to the right, followed by the second
row from top to bottom. The position of an image in 3D space is indicated in a coordinate
system using orientation and position 3D vectors. Orientation vectors indicate how much
an image is rotated with respect to its coordinate system, and the position vector indicates
the location of the image with respect to the origin. Orientation vectors are given by
the Image Orientation (Patient) attribute. It contains two triplets, the first triplet values
(direction cosines) represent the vector for the image orientation of the X-axis, and the
second triplet values indicate the vector for the image orientation of the Y-axis [45].
Figure 30: Image coordinate system of a 2D image. Image downloaded from
https://www.slicer.org/wiki/Coordinate systems.
A Head First Supine (HFS) scan position is a simple case where the patient-based
coordinate system is aligned with the imaging system. As we move along the image
columns (from left to right of the image), we are also moving on the positive direction on
the X axis of the patient (from the right hand of the patient to the left hand). The same
applies for the Y axis. As we move along the image rows (from top to bottom of the
image), we are also moving on the positive direction on the Y axis of the patient (from
the anterior side of the patient to the posterior).
Only HFS scans are supported by the application because this position is the used for
patients undergoing radiosurgery. Conversion of a voxel P with coordinates Px,y,z in the
patient-based coordinate system to the image coordinate system is simplified and can be
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performed using the equation:
Pc,r,s =
Px,y,z −Ox,y,z
Vx,y,z
(6.19)
Where Pc,r,s is the triplet with the column, row and slice indexes in the image coordinate
system, Px,y,z is the triplet with the x, y and z position in the patient-based coordinate
system (in mm), Ox,y,z is the CT origin triplet (in mm) and Vx,y,z is the voxel size triplet
in x, y and z directions in the patient based coordinate system (in mm). This equation
assumes that the first index of an array starts at 0 position, however, arrays in MATLAB®
starts at position 1, so equation (6.19) becomes:
Pc,r,s =
Px,y,z −Ox,y,z
Vx,y,z
+ (1, 1, 1) (6.20)
Row and column are purposely flipped in Pc,r,s triplet because X direction corresponds to
the image columns and Y direction corresponds to the image rows. After the flip, Pc,r,s
becomes Pr,c,s.
6.2.5.2 DICOM data files import and processing
CT images
The following DICOM attributes are read:
• Instance Number: Image identification number.
• Image Position (Patient): The X, Y, and Z coordinates of the upper left hand corner
(center of the first voxel transmitted) of the image, in mm.
• Image Orientation (Patient): The direction cosines of the first row and the first
column with respect to the patient.
• Patient Position: Patient position relative to the imaging equipment space.
• Pixel Spacing: Physical distance in the patient between the center of each pixel,
specified by a numeric pair (adjacent row spacing and adjacent column) spacing in
mm.
• Window Center: Acquisition Window Center value.
• Window Width: Acquisition Window Width value.
• Rescale Slope / Rescale Intercept: Constants that specify the linear
transformation from pixels stored on disk to an output unit. In CT images, it maps
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the pixel values to HU.
U = m× SV + b (6.21)
Where U is the output unit, m is the Rescale Slope, SV is the stored value in the
pixel of the CT image and b is the Rescale Intercept. In CT images, the output is
the HU value.
DICOM metadata gives the Pixel Spacing attribute, however, there is no attribute for
Slice Spacing and it needs to be computed based on the Image Position (Patient) of two
consecutive CT slices:
Slice Spacing = |Z2 − Z1| (6.22)
Where Z2 is the longitudinal distance, in mm, from the CT origin to the second acquired
image and Z1 is the longitudinal distance, in mm, from the CT origin to the first acquired
image. Z2 and Z1 are the third value of Image Position (Patient) triplet for both CT slices.
CT images are saved in a 3D array (from now on, a multi-dimensional array will be called
matrix). The first two dimensions are the rows and columns (i, j) of the CT image; the
third dimension are the CT slices (k).
RT Structure Set
Data from structures are stored in various sub-fields inside the RTSTRUCT file metadata.
The following sub-fields are read for each structure:
• Structure Set ROI Sequence
Structure Set ROI Sequence
ROI Number ROI Name
Figure 31: Data extracted from Structure Set ROI Sequence.
Structure Set ROI Sequence stores basic information about every structure: ROI
Number is a integer assigned to the structure that allows it to be referenced internally in
the multiple metadata sub-fields; ROI Name is the name of the structure.
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• ROI Contour Sequence
ROI Contour Sequence
Contour
Sequence
ROI Display
Color
Figure 32: Data extracted from ROI Contour Sequence.
ROI Contour Sequence contains the slice contours of each structure, only present if the
structure contain at least one planar contour. If it does not contain at least one planar
contour it means that the structure is empty and therefore, it is not processed. This
sequence also contains the display colour (red, green and blue (RGB) triplet) of the
structures.
Contour Sequence attribute contains the contours of every slice contoured of every
structure.
ROI Contour Sequence
Structure 1 Structure 2 Structure N
Contour
Sequence 2
Contour
Sequence 1
Contour
Sequence N
Contour Data Contour Data Contour Data
...
...
Figure 33: Contour Data extracted from ROI Contour Sequence.
Contours are saved as points under Contour Data attribute. Each point is saved as a
triplet with its x, y and z coordinates in relation to the CT origin. A contour is only valid
if its geometric type is CLOSED PLANAR. This can be verified reading the Contour
Geometric Type of every Contour Sequence created.
The application reads all the contour points stored under each Contour Data attribute
and creates a polygon.
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Figure 34: Patient external contour with its contour points on the left and the polygon on the right.
The polygon is useful to determine which voxels belong to the contoured structure. Pixels
inside the polygon are inside the contoured structure and they have a value of 1. Every
other pixels have a value of 0. This will create a binary image (with the same rows and
columns of the CT scan) for every Contour Sequence.
In the end, binary images of all Contour Sequence instances are merged in a 3D matrix
with the same dimensions of the CT scan. This is repeated for each structure so each
one will have a matrix in which each voxel that belongs to the contour has a value of 1.
Figure 35: Patient 3D reconstruction of its external contour.
• ROI Observations Sequence
Density overrides defined in the TPS are stored under the ROI Observations Sequence
attribute. If a structure has an HU value assigned, its corresponding RED is read from
ROI Physical Property Value attribute:
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ROI Observations Sequence
ROI Physical Properties Sequence
ROI Physical Property ROI Physical Property Value
Figure 36: Data extracted from ROI Observations Sequence.
Since ROI Physical Property attribute can assume multiple physical properties (such
as relative electron density or relative mass density), this attribute should be equal to
REL ELEC DENSITY in order to read ROI Physical Property Value properly as a RED
value.
RT Plan
RTPLAN file metadata contains data of all setup/treatment fields, reference points and
the LINAC tolerance table used, in multiple sub-fields. Only data from treatment fields
is read from the file metadata under the Beam Sequence and Fraction Group Sequence
attributes.
• Beam Sequence
The Beam Sequence attribute contains all beam parameters. Beam Number is a integer
assigned to the beam that allows it to be referenced internally in the multiple metadata
sub-fields; Beam Name is the name of the field; Beam Type determines if the field is
static or in arc. Source-Axis Distance is also read just to verify if it matches the SAD
loaded from the ”Beam Configuration” MAT-File. Applicator Sequence stores the nominal
cone diameter used in the beam.
The Control Point Sequence attribute contains all control points of the beam since the start
of the irradiation until the end. Control points are snapshots of the system at a discrete
time. They play an important role in IMRT and volumetric arc therapy (VMAT) treatments
where MLC leaves and dose rate changes during the irradiation. A control point is created
every time a beam parameter changes such as gantry rotation, MLC leaves position or
dose rate. Hundreds of control points per field might be created for these techniques.
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Figure 37: Data extracted from Beam Sequence.
A static field only has one control point because beam parameters do not change during
irradiation. An arc field with stereotactic cones has two control points: the initial control
point where all beam parameters are defined and a second control point indicating the
final gantry angle. No more control points are created because there are no beam
parameters changing during the irradiation.
Beam Type
STATIC DYNAMIC
Control Point 1 Control Point 1(initial gantry angle)
Control Point 2
(final gantry angle)
Figure 38: Control Points extracted from Beam Sequence.
The following attributes are extracted from the first control point:
• Gantry Rotation Direction: The direction of gantry rotation. Only used if the field
is an arc. It can be clockwise or counter-clockwise.
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• Gantry Angle: Gantry angle with respect to the IEC FIXED REFERENCE
coordinate system. For arc fields, it is the initial gantry angle.
• Patient Support Angle: Couch rotation with respect to the IEC FIXED
REFERENCE.
• Beam Limiting Device Angle: Collimator rotation with respect to the with respect
to the IEC FIXED REFERENCE.
• Nominal Beam Energy: Energy of the beam.
• Isocenter Position: Isocenter position in relation to the CT origin.
• Source to Surface Distance: SSD of the beam. For arc fields, it is the SSD of the
initial gantry angle.
The second control point is used only to extract the final gantry angle.
• Fraction Group Sequence
The Fraction Group Sequence contains the dose that each field contributes to a specific
point and the MU per field, for one treatment fraction, under the Referenced Beam
Sequence sub-field in the Beam Meterset attribute. It also contains the number of planned
fractions in the Number of Fractions Planned attribute.
Fraction Group Sequence
Number of Fractions
Planned
Referenced Beam
Sequence
Beam Dose Beam Meterset
Figure 39: Data extracted from Fraction Group Sequence.
The dose at a specific point is given by the Beam Dose attribute. The point coordinates in
relation to the CT origin is given by the Beam Dose Specification Point attribute, however,
if the user does not create this point manually during the planning, it is omitted from
the DICOM RTPLAN metadata. If the Beam Dose Specification Point is omitted from
the DICOM metadata, Beam Dose can’t be used to determine the dose that each field
contributes to the isocenter. However, Beam Dose can be used to calculate the weight of
each field.
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Relative weight Wi of beam i is given by:
Wi =
BDi
BDtotal
(6.23)
Where BDi is the Beam Dose attribute value for beam i and BDtotal is the sum of all
Beam Dose attribute values of all treatment fields.
The dose at the isocenter of each field (per fraction) is then calculated using the dose of
the isocenter nearest voxel, extracted from RT Dose metadata file.
IDi =
IDtotal
fractions
×Wi (6.24)
Where IDi is the dose at the isocenter of field i (per fraction), IDtotal is the dose of the
isocenter nearest voxel, divided by the number of fractions and Wi is the relative field
weight calculated on equation (6.23).
The total dose at the isocenter is obtained in the 3D calculation volume, as will be
explained next.
RT Dose
RT Dose
Dose Units Dose GridScaling Pixel Spacing
Image Position
(Patient)
Grid Frame
Offset Vector
Figure 40: Data extracted from RT Dose.
RTDOSE file metadata contains the 3D calculation volume and the dose volume
histogram (which is not used). The 3D calculation volume comes in a matrix with
arbitrary values. To convert the matrix elements to absolute dose in Gray, RT Dose file
must be exported from the TPS as absolute dose and not relative dose. This verification
is done with the Dose Units attribute value. It should be equal to GY and not
RELATIVE. Every matrix element is then multiplied by the Dose Grid Scaling attribute
value.
In order to match the 3D dose calculation volume with the CT scan, they must have the
same voxel size and dimensions (same number of rows, columns and slices).
The calculation resolution is chosen during the treatment planning and usually it is
isotropic (same value for pixel and slice spacing). Pixel spacing is read from Pixel
Spacing attribute and slice spacing is derived from the Grid Frame Offset Vector, which
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contains a given slice offset from the first slice in millimeters. If the voxel size of the dose
matrix does not match the CT, dose matrix is resampled with linear interpolation.
The last step is the dose matrix registration with the CT scan. By having the coordinates
of the first voxel transmitted (upper left corner of the first dose slice) from Image Position
(Patient) attribute in RT Dose metadata, registration can be done. This is needed
because normally the dose matrix has smaller dimensions than the CT scan. The
calculation box area is defined during the treatment planning and is placed around the
outer contour of the patient or phantom.
Figure 41: CT and dose matrices before the registration. RD X, RD Y and RD Z are the coordinates of the
upper left corner of the first dose slice. Image adapted from Clinical Radiotherapy Physics with MATLAB®
(Pavel Dvorak, 2018).
After the registration, the new dose matrix created matches the dimensions of the CT
scan (same number of rows, columns and slices). Every voxel that is outside the old
dose matrix is assigned with no dose (0 Gy).
Plans calculated in CDC workspace and exported from Eclipse™ might have a 3D dose
calculation volume outside the CT scan. This happens because CDC automatically
adjusts the dose calculation volume area, however, it may adjust beyond the CT area for
an unknown reason. In this case, dose voxels beyond the CT scan are discarded.
6.2.5.3 MU calculation without heterogeneity correction
With all beam configuration data and patient DICOM data imported, the required MU of
each field per treatment fraction can be calculated.
MU calculation is based on equation (5.1) from CDC algorithm:
D(r, d, SSD, S) = MU×DRref×OFTMRmax(S)×TMR(d, S)×
(
SAD
SSD + d
)
×OAR(r, S)
(6.25)
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To calculate MU instead of dose:
MU =
D(r, d, SSD, S)
DRref ×OFTMRmax(S)× TMR(d, S)×
(
SAD
SSD+d
)
×OAR(r, S)
(6.26)
Since MU calculations are performed at the isocenter, there is no lateral shift and there
is no need to apply a inverse square law correction:
OAR(r, S) = 1
And: (
SAD
SSD + d
)
= 1
Equation (6.26) is then reduced to:
MU =
D(r, d, SSD, S)
DRref ×OFTMRmax(S)× TMR(d, S)
(6.27)
The reference dose rate, DRref , is:
DRref =
(
Dref
MUref
)
(6.28)
And OFTMRmax(S) is the output factor corrected for the depth of maximum dose:
OFTMRmax(S) = OF (S)×
PDD(S, SSD, dmax)
PDD(S, SSD, d)
×
(
SSD + dmax
SAD
)2
(6.29)
Equation (6.27) can be rewritten as:
MU =
D(r, d, SSD, S)(
Dref
MUref
)
×OF (S)× PDD(S,SSD,dmax)PDD(S,SSD,d) ×
(
SSD+dmax
SAD
)2 × TMR(d, S) (6.30)
The dose at the isocenter is given by D(r, d, SSD, S). For a single treatment fraction this
value is given by equation (6.24) discussed in the RT Plan section. The reference dose-
rate,
(
Dref
MUref
)
, is stored in the beam data configuration and only depends on the LINAC
and energy of the beam.
OF depends on the collimator size used and is read directly from the beam configuration
data. The OF correction for the depth of maximum dose is the OF multiplied by the
quotient between the PDD at dmax and the PDD at the depth of which OF were taken,
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multiplied by the inverse square law correction factor:
OFTMRmax(S) = OF (S)×
PDD(S, SSD, dmax)
PDD(S, SSD, d)
×
(
SSD + dmax
SAD
)2
(6.31)
PDD at dmax is assumed to be 100 so the quotient between both PDDs becomes:
100
PDD(S, SSD, d)
Where S is the nominal collimator diameter, SSD and d are the SSD and depth taken in
OF measurements, respectively. PDD calculation is derived from TMR using a equation
proposed by L J van Battum et al. [46].
TMR(d, rd) =
Dinf (d, rd)
Sc,p(r∗s)
=
PDD(d, rs, f)× Sc,p(rs)×
(
f+d
f+t0
)2
Sc,p(r∗s)
(6.32)
Where,
• d = depth;
• rd = field size defined at depth d;
• TMR(d, rd) = TMR value at depth d;
• Dinf (d, rd) = depth dose curve that represents a curve corrected for source-detector
distance (infinite focus);
• f = source-phantom distance;
• r∗s = rd ×
(
f+d−t0
f+d
)
;
• Sc,p(r∗s) = output factor at field size r∗s ;
• rs = rd ×
(
f
f+d
)
, field size defined at the surface of the phantom;
• PDD(d, rs, f) = PDD value at depth d and field size rs defined at the surface of the
phantom;
• Sc,p(rs) = output factor at field size rs defined at the surface of the phantom;
• to = depth of maximum dose.
PDD at depth d and field size rs defined at surface is given by:
PDD(d, rs, f) = TMR(d, rd)×
(
Sc,p(r
∗
s)
Sc,p(rs)
)
×
(
f + t0
f + d
)2
(6.33)
Sc,p(r
∗
s) for an arbitrary field size can be calculated using the OF two-term exponential
curve fit as defined in equation (6.18).
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TMR(d, S) is the remaining term in equation (6.30) that needs to be determined and is
the only one that depends on the depth. All the others are constants (such as DRref ) or
are directly dependent on the reference conditions and cone size used (such as
OFTMRmax(S)).
TMR calculation has a different approach depending if the beam is static or arc. The
calculation is simplified if the beam is static: only depth needs to be calculated in order
to obtain the TMR value from the beam data. For arc beams, the average TMR is
calculated instead. The arc is segmented in multiple incident gantry angles (with 1º
resolution between each incident gantry angle) and for each gantry angle, depth is
calculated to obtain the TMR value. In the end, the average TMR is used in equation
(6.30).
Beam Type
Static Arc
Determine incident
gantry angles
Arc
resolution
Calculate depth
Determine TMR
Determine average
TMR
Calculate depth
Determine TMR
Figure 42: TMR calculation of static or arc treatment fields.
An arc resolution of 1º was chosen because it improves the accuracy of the average TMR
calculation in arc fields. Irregular surfaces such as the nose and the ears of patients may
benefit from shorter arc resolutions. A comparison between 1º and 10º arc resolution
in TMR calculation is shown of figure 43. This value can be changed in CDC algorithm
between 1º and 10º, however, in this application the value is fixed and cannot be changed.
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Figure 43: TMR factor in function of gantry angle with 1º and 10º arc resolution. Average TMR factor for both
resolutions is displayed in dashed lines. Data is from a non-coplanar arc of a patient plan.
Depth calculation is based on the CT scan and on the external contour. A structure
representing the external contour with ROI Interpreted Type equal to EXTERNAL must
exist in the RT Structure Set file.
For static fields the depth can be calculated using the Source to Surface Distance attribute
value:
Depth = SAD − SSD (6.34)
However, equation (6.34) is not used and depth is calculated from scratch, for both static
and arc fields.
Depth is the distance between the beam entry point on the surface of the patient/phantom
and the isocenter location, along the CAX. For a given CT scan and RT Structure Set with
the external contour, the depth depends on the gantry angle and couch rotation.
The following steps are executed to calculate the depth in metric units:
1. Obtain the CT origin in the image coordinate system:
CToriginc,r,s =
−CToriginx,y,z
Vx,y,z
+ (1, 1, 1) (6.35)
Where CToriginc,r,s is the CT origin in the image coordinate system, CToriginx,y,z
are the coordinates of the upper left corner of the first transmitted image (Image
Position (Patient) attribute value from CT scan). Vx,y,z is the voxel size in x, y and
z directions. Rows and columns are flipped because X direction corresponds to
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the matrix columns and Y direction corresponds to the matrix rows. After the flip,
CToriginc,r,s becomes CToriginr,c,s.
2. Obtain the isocenter displacement from the CT origin in the image coordinate
system:
IsocenterOffsetc,r,s =
IsocenterOffsetx,y,z
Vx,y,z
(6.36)
Where IsocenterOffsetc,r,s is the offset from the CT origin in the image coordinate
system, IsocenterOffsetx,y,z is the Isocenter Position attribute value and Vx,y,z is the
voxel size in x, y and z directions. Rows and columns are flipped for the same
reason above. After the flip, IsocenterOffsetc,r,s becomes IsocenterOffsetr,c,s.
3. Get the isocenter position related to the upper left corner voxel of the first
transmitted image:
Isocenterr,c,s = CToriginc,r,s + IsocenterOffsetr,c,s (6.37)
4. Find the target (X-Ray source) position offset from the isocenter in metric units:
TargetOffsetx,y,z =

x = SAD× cos(CouchRTN)× sin(GantryRTN)
y = −SAD× cos(GantryRTN)
z = −SAD× sin(CouchRTN)× sin(GantryRTN)

Where SAD is the source-axis distance, CouchRTN is the couch angle and
GantryRTN is the gantry angle, both with respect to the IEC FIXED REFERENCE
coordinate system.
5. Get the target position offset from the isocenter in the image coordinate system:
TargetOffsetc,r,s =
TargetOffsetx,y,z
Vx,y,z
(6.38)
Where Vx,y,z is the voxel size in x, y and z directions. Rows and columns are
flipped for the same reason above. After the flip, TargetOffsetc,r,s becomes
TargetOffsetr,c,s.
6. Get the increment between the isocenter and the target, dividing TargetOffsetr,c,s
by its Euclidean norm:
Incrementr,c,s =
TargetOffsetr,c,s√|TargetOffsetr|2 + |TargetOffsetc|2 + |TargetOffsets|2 (6.39)
Incrementr,c,s is a triplet with the increment values in rows, columns, slices.
7. Loop from the starting point (the isocenter location) to the target position with the
increment values defined above. For each new position, the algorithm verifies if
the current voxel is inside the external contour of the patient or phantom. This
verification is done using the binary matrix created during the RT Structure Set
processing. A value of 1 means that the current voxel is inside the external contour.
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In this case, the algorithm continues to the next voxel. A value of 0 means that the
current voxel no long belongs to the external contour. The last voxel that belongs
to the external contour is saved as the beam entry point on the patient/phantom
(BEPrcs). The loop stops when the limits of the CT matrix are reached.
8. Get the offset coordinates between the isocenter and the beam entry point on the
patient/phantom:
BEPOffsetr,c,s = BEPr,c,s − Isocenterr,c,s (6.40)
9. Convert the previous offset coordinates to metric units:
BEPOffsety,x,z =
BEPOffsetr,c,s
Vy,x,z
(6.41)
BEPOffsety,x,z is a triplet with the distance in y, x and z directions from the isocenter
to the beam entry point on the patient/phantom and Vy,x,z is the voxel size in y, x
and z directions. After the flip, BEPOffsety,x,z becomes BEPOffsetx,y,z.
10. Finally, depth in metric units (mm) is given by:
Depth =
√
|BEPOffsetx|2 + |BEPOffsety|2 + |BEPOffsetz|2 (6.42)
Depth is then used to determinate the TMR value for static fields or the average TMR
value for arc fields using the beam data of the LINAC and energy imported.
With all terms of equation (6.30) determined, MU of all treatment fields per treatment
fraction without heterogeneity correction can be calculated and compared to the MU
calculated by CDC algorithm. The difference is given by:
Difference (%) =
MUNHC −MUCDC
MUCDC
× 100 (6.43)
Where MUNHC is the number of MU calculated by the application without heterogeneity
correction and MUCDC is the number of MU calculated by CDC algorithm.
6.2.5.4 MU calculation with heterogeneity correction
MU calculation with heterogeneity correction shares the same equation used before in
MU calculation without heterogeneity correction. The only exception is the depth which
is replaced by the effective depth, deff , in TMR calculation:
MU =
D(r, d, SSD, S)
DRref ×OFTMRmax(S)× TMR(deff , S)
(6.44)
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Effective depth or equivalent path length (EPL) is the distance in tissue weighted by the
relative electron density of that tissue to water. It is a method to correct heterogeneities
inside the patient body such as bones or air cavities, however, this basic 1D
inhomogeneity correction only works well for points that are far away from
inhomogeneities. It does not represent the dose within the inhomogeneity because it
does not consider the modifications of the scatter component, which has a greater
influence within or close the inhomogeneity [22].
EPL in the algorithm created in this work is defined as:
EPL = deff =
∑
i
ρeli × xi (6.45)
Where i represents each CT voxel along a given rayline between the isocenter and the
target, ρeli is the relative electron density of voxel i and xi is the voxel dimension along a
given rayline.
Figure 44: EPL method illustration. The attenuation at point P for a thickness tm of material with density ρm
is the same as for a scaled thickess tw of water where tw = tm × ρm. Image adapted from Handbook of
Radiotherapy Physics, (Phylip Mailes, et al., 2007).
EPL calculation along a given ray line uses the first 6 steps of depth calculation discussed
in the previous section. From this step forward, a loop is made from the starting point (the
isocenter location) to the target position with the increment values defined in equation
(6.39). For each loop interaction, the algorithm calculates the RED value of the voxel and
then multiplies it by the increment distance.
First, the increment between each loop interaction is calculated in metric units:
Incrementy,x,z =
Incrementr,c,s
Vy,x,z
(6.46)
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Incrementr,c,s was defined in equation (6.39). Vy,x,z is the voxel size in y, x and z
directions. After the rows/columns flip, Incrementy,x,z becomes Incrementx,y,z.
The increment distance in metric units between each loop interaction is then calculated:
IncrementDistance =
√
|Incrementx|2 + |Incrementy|2 + |Incrementz|2 (6.47)
EPL between each loop interaction is given by:
EPLi = ρ
el
i × xi (6.48)
Where i represents each CT voxel along the ray line, EPLi is the EPL of voxel i, ρeli is the
RED value of voxel i and xi is IncrementDistance between each loop interaction, defined
in equation (6.47).
When the loop reaches the patient or phantom external contour, it finishes the EPL
count. At this point, EPL is the sum of all contributions of EPLi along the ray line and is
given in metric units (mm). However, the loop continues until it reaches the CT matrix
limits because it may exist contoured structures with custom density assigned outside
the patient or phantom external contour, such as the LINAC couch or the patient mask
support. This type of structures will increase the EPL, even if they are outside the
external contour. Structures outside the external contour that attenuate radiation
considerably should be contoured and assigned with the respective material density. If
they are contoured but without any custom density assigned, the algorithm will not count
them to the EPL calculation.
RED calculation depends on the voxel HU and CT calibration curve. If the voxel belongs
to a structure with custom density assigned, the RED value used is read directly from the
the RT Structure Set metadata file. If the voxel belongs to multiple structures with density
override, the RED value used is the highest of them. In this case, and if the external
contour also has a density override defined, its RED value is ignored. If the voxel belongs
to a structure without custom density assigned, its RED value is obtained from the CT
calibration curve using the voxel HU.
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Figure 45: Voxel RED calculation.
The difference between the MU of all treatment fields per treatment fraction with
heterogeneity correction and the MU calculated by CDC is given by:
Difference (%) =
MUWHC −MUCDC
MUCDC
× 100 (6.49)
Where MUWHC is the number of MU calculated by the application with heterogeneity
correction and MUCDC is the number of MU calculated by CDC algorithm.
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6.2.6 Algorithm validation
The developed MATLAB® algorithm was tested in different MU calculation scenarios, with
and without heterogeneity correction. Several tests were performed because many data
is processed. Initially, beam data including TMR, OAR and OF is processed in ”Beam
Configuration” application. Then, DICOM patient data is processed in ”Stereotactic MU
Calculator” application. To despite any MU calculation error, all energies on both LINACs
were tested with multiple collimators (a small, an intermediate and a large collimator when
possible).
An additional test to verify depth calculation was performed because depth and effective
depth are calculated from scratch and they can influence TMR value. For instance, at
5 cm depth, a depth calculation error of 1 mm leads to a difference of 0.4% to 0,5% in
TMR calculation, reflecting a dose difference of 1% if the depth calculation error is 2 mm.
6.2.6.1 Depth calculation
Depth calculation was validated in Lucy® 3D QA phantom, simulating real treatment plans
with multiple static fields using different isocenters, gantry angles and couch rotations
(table 16). SSD was calculated from depth and compared to the planned SSD from TPS.
Plans were created for TrueBeam™ STx. There is no need to verify depth calculation in
Novalis Tx™ because the method is the same for both LINACs.
Table 16: Static field parameters used to validate depth calculation.
Gantry Rtn. (º) Couch Rtn. (º) TPS SSD (cm)
0 0 93.8
90 0 91.6
210 0 94.8
0 20 93.8
80 90 90.7
210 340 94.4
6.2.6.2 MU calculation without heterogeneity correction
Static fields and arcs with coplanar and non-coplanar beams were used to validate MU
calculation without heterogeneity correction. Beam parameters used for TrueBeam™
STx and Novalis Tx™ are given on appendix B.1.
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6.2.6.3 MU calculation with heterogeneity correction
MU calculation with heterogeneity correction cannot be compared to CDC because this
algorithm does not have into account heterogeneities. Instead, the dose calculated by the
developed algorithm was compared to the absorbed dose measurement in a QUASAR™
thorax phantom.
QUASAR™ thorax phantom was chosen because it has multiple insert locations and it is
possible to choose inserts with different densities and sizes. The phantom has 5 small
inserts with different densities, from a RED of 0.25 to a RED of 1.36. It also has two big
inserts of cedar wood and acrylic [47].
Inner Bone
RED 1.09
Water
Equivalent
RED 1.01
Lung Inhale
RED 0.25
Polyethylene
RED 0.945
Dense Bone
RED 1.36
Figure 46: QUASAR™ thorax phantom small inserts available.
To simulate lung and bone, the cedar wood insert and the bone insert with a RED of 1.36
were chosen, respectively. The lowest density insert was placed in the left side of the
phantom, in the left lung insertion. The highest density insert was placed in the central
bottom insertion of the phantom, in the vertebrae position, to simulate bone.
The ionization chamber was placed at the isocenter (the intersection of the 3 external
markers) in a special insert designed for the detector. CT scan was acquired without the
ionization chamber. It was replaced by an insert with the same density as the ionization
chamber special insert during the CT scan.
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Figure 47: QUASAR™ thorax phantom axial plane with cedar wood inserts on the lungs position and bone
insert on the vertebrae position.
To study the attenuation of cedar wood and bone densities, a lateral beam (incident on
the lung insert) and a posterior beam (incident on the bone insert) were used. The dose
absorbed by the ionization chamber on both beams should be different from the planned
dose at the isocenter because cedar wood attenuates less radiation than water and bone
attenuates more radiation. An additional arc incident on the lung insert and on the bone
insert during its trajectory was used to validate the MU calculation with heterogeneity
correction on arcs. Couch attenuation was taken in consideration to the calculation of the
effective depth.
The static fields and arcs used are shown on the next figure:
(a) 90º static field (b) 180º static field (c) Arc 0º − > 180º
Figure 48: Static fields and arcs used to validate the MU calculation with heterogeneity correction using the
QUASAR™ thorax phantom.
MU calculation with heterogeneity correction is strongly dependent on the effective depth
calculation. A manual calculation of the effective depth for both static fields is presented
in the 7.5.3 chapter. On the same chapter, the manual calculations are compared to the
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effective depth calculated by the MATLAB® algorithm.
A PTW PinPoint 3D 31016 was used to measure the dose at the center of the phantom.
Output correction factors from TRS-483 were used.
6.2.6.4 Patient plans MU verification
The final verification and validation were performed in patient plans. Radiosurgery
patients previously treated at IPO Porto in TrueBeam™ STx and Novalis Tx™ LINACs
were randomly chosen. Differences between the MU calculated by CDC and the MU
calculated by the developed algorithm, with and without heterogeneity corrections, were
obtained using the following equations:
Difference WHC (%) =
MUWHC −MUCDC
MUCDC
× 100 (6.50)
Difference NHC (%) =
MUNHC −MUCDC
MUCDC
× 100 (6.51)
Where MUWHC and MUNHC are the number of MU calculated by the developed
algorithm with and without heterogeneity correction respectively and MUCDC is the
number of MU calculated by CDC algorithm.
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7 Results and Discussion
7.1 Absolute Dosimetry
Absolute dosimetry was performed during the commissioning for both LINACs . Data was
extracted from TPS in CDC configuration algorithm:
Table 17: Absolute dosimetry results in reference conditions. Dose is corrected for influence quantities.
LINAC Energy Ref. MU Ref. Dose (Gy)
TrueBeam™ STx 6 FFF 100.00 0.925
TrueBeam™ STx 10 FFF 100.80 1.000
Novalis Tx™ 6X SRS 106.05 1.000
7.2 Relative Dosimetry
7.2.1 OF
For OF calculation some equivalent square field size correction factors were used. Table
26 from TRS-483 presents the correction factors for the detector used, PTW
microDiamond 60019. This table specifies the OF correction factors for fields collimated
by MLC or SRS cones for 6 MV WFF and FFF energies, as a function of the equivalent
square field size. Correction values for 10 MV WFF and FFF energies are specified in
Table 27 of TRS-483.
Table 18: TrueBeam™ STx and Novalis Tx™ cone size with the equivalent square field size and the
corresponding OF correction factor, for 6 FFF, 10 FFF and 6X SRS energies using PTW microDiamond
60019 detector.
Cone Size (mm) Eqv. Square Field Size (mm) Correction factor
4.0 3.545 0.95134
5.0 4.431 0.95815
6.0 5.317 0.96402
7.5 6.647 0.97133
10.0 8.862 0.98039
12.5 11.078 0.98661
15.0 13.293 0.99089
17.5 15.509 0.99383
The cone equivalent square field size was determined with equation (6.3). Correction
factors were fitted into a two term exponential curve, defined in equation (6.4). The
following curve fit coefficients were obtained:
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Coefficients (with 95% confidence bounds):
a = 1 (0.9998, 1.001)
b = -5.902e-06 (-1.829e-05, 6.488e-06)
c = -0.08929 (-0.09115, -0.08743)
d = -0.1689 (-0.1744, -0.1633)
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Figure 49: OF correction factors for PTW microDiamond 60019 as a function of the equivalent square field
size. Red dots are the TrueBeam™ STx and Novalis Tx™ cones equivalent square field size. Valid for 6
FFF, 10 FFF and 6X SRS energies.
OF were determined using equation (6.2). For every cone size, the detector was
irradiated with 100 MU at 95 cm SSD and 5 cm depth. The next two tables summarizes
the OF values calculated, with correction factors applied, for TrueBeam™ STx and
Novalis Tx™.
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Table 19: TrueBeam™ STx OF table for 6 FFF and 10 FFF.
Cone Size (mm) OF 6 FFF OF 10 FFF
4.0 0.56176 0.47354
5.0 0.63126 0.54974
7.5 0.72391 0.66245
10.0 0.77311 0.73110
12.5 0.81570 0.79056
15.0 0.83532 0.82468
17.5 0.85294 0.85303
Table 20: Novalis Tx™ OF table for 6X SRS.
Cone Size (mm) OF 6X SRS
4.0 0.55188
6.0 0.65918
7.5 0.70837
10.0 0.76564
12.5 0.79668
15.0 0.82215
A two term exponential curve fit, defined in equation (6.18), was applied to the OF values
with correction factors. The following coefficients were obtained:
Coefficients for 6 FFF (TrueBeam STx) (with 95% confidence bounds):
a = 0.7452 (0.6324, 0.858)
b = 0.008005 (-0.0007622, 0.01677)
c = -0.7526 (-1.102, -0.4032)
d = -0.3246 (-0.5279, -0.1213)
Coefficients for 10 FFF (TrueBeam STx) (with 95% confidence bounds):
a = 0.7078 (0.5332, 0.8825)
b = 0.01132 (-0.001915, 0.02455)
c = -0.7424 (-0.9349, -0.5498)
d = -0.2582 (-0.4339, -0.08248)
Coefficients for 6X SRS (Novalis Tx) (with 95% confidence bounds):
a = 0.7472 (0.6434, 0.8509)
b = 0.007059 (-0.001369, 0.01549)
c = -0.695 (-0.8025, -0.5874)
d = -0.2915 (-0.4103, -0.1726)
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A plot of the OF values obtained for both LINACs are shown on the next two figures along
with the exponential curve obtained for each energy.
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Figure 50: TrueBeam™ STx OF two term exponential curve for 6 FFF and 10 FFF.
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Figure 51: Novalis Tx™ OF two term exponential curve for 6X SRS.
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7.2.2 TMR
TMR was acquired for 4, 7.5, 10 and 17.5 mm stereotactic cones for TrueBeam™ STx.
For Novalis Tx™, cones 4, 6, 10 and 15 mm were acquired. The remaining cones were
interpolated.
The following graphics shows the genuine TMR curves acquired without any processing
for TrueBeam™ STx (6 FFF / 10 FFF) and Novalis Tx™ (6X SRS).
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Figure 52: TrueBeam™ STx acquired TMR for 6 FFF energy without any enhancements.
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Figure 53: TrueBeam™ STx acquired TMR for 10 FFF energy without any enhancements.
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Figure 54: Novalis Tx™ acquired TMR for 6X SRS energy without any enhancements.
Data was smoothed to decrease the measurement noise, according to the different
methods explained in the chapter 6.2.4.2. The resulting smoothed TMR curves are
presented in appendix A.1 for TrueBeam™ and in appendix A.2 for Novalis Tx™.
Figures 75, 77 and 79 shows TMR data smoothed with a local regression method using
weighted linear least squares and a 2nd degree polynomial model. Figures 76, 78 and
80 shows TMR data fited into a two-term exponential model, defined previously in
equation (6.11).
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7.2.3 OAR
OAR was acquired for all cones. The irradiation conditions for OAR displayed below were
95 cm SSD and 5 cm depth. No smoothing was applied because curves come with no
noise. Curves were averaged (negative side with positive side) and then cut in half.
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Figure 55: TrueBeam™ STx OAR for 6 FFF energy.
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Figure 56: TrueBeam™ STx OAR for 10 FFF energy.
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Figure 57: Novalis Tx™ OAR for 6X SRS energy.
7.3 FWHM film measurements
FWHM film measurements were performed on TrueBeam™ STx LINAC using 6 FFF
energy.
7.3.1 Calibration curve
The MPV of red, green and blue colour channels of each irradiated film including the
background film are displayed below:
Table 21: MPV of all colour channels.
Dose (Gy) MPV Red MPV Green MPV Blue
0 (Background) 46805 44864 30294
0.422 42183 42572 29981
0.844 39011 40830 29899
1.689 33832 37585 29437
3.377 27466 32597 28371
6.754 20757 26258 26313
8.443 18703 24256 25223
12.665 15214 20434 23331
16.886 12999 17607 21582
21.108 11358 15205 20251
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The following netOD values were obtained using equation (6.5):
Table 22: netOD of all colour channels.
Dose (Gy) netOD Red netOD Green netOD Blue
0.422 0.04515 0.02278 0.00451
0.844 0.07910 0.04092 0.00571
1.689 0.14096 0.07689 0.01247
3.377 0.23150 0.13873 0.02848
6.754 0.35312 0.23263 0.06119
8.443 0.39839 0.26709 0.07957
12.665 0.48806 0.34154 0.11342
16.886 0.55637 0.40622 0.14728
21.108 0.61499 0.46991 0.17493
Only red channel was used. The netOD values for this channel were fitted in the 4th
polynomial degree of equation (6.6). The function coefficients were the following:
Coefficients (with 95% confidence bounds):
a = 206 (131.2, 280.8)
b = -179.3 (-290.2, -68.49)
c = 84.39 (32.9, 135.9)
d = 2.98 (-4.533, 10.49)
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Figure 58: EBT3 calibration curve.
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7.3.2 Film analysis
Figure 59: Red channel in jet colour scale of all TrueBeam™ STx collimators. Images are ordered from the
smallest to the largest cone, from the left to the right, from the top to the bottom.
The following table compares the FWHM measured by film irradiation and through PTW
microDiamond (extracted from OAR curves). The difference between them is shown in
the last column.
Table 23: TrueBeam™ STx stereotactic cones FWHM measured by film irradiation and microDiamond.
Cone Size (mm) Film FWHM (mm) microDiamond
FWHM (mm)
Difference (mm)
4 3.797 3.762 +0.035
5 4.875 4.756 +0.119
7.5 7.253 7.226 +0.027
10 9.644 9.658 -0.014
12.5 12.074 12.122 -0.048
15 14.599 14.580 +0.019
17.5 16.963 17.018 -0.055
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7.4 CT calibration curve
The calibration curve used was the curve obtained for the TPS commissioning, as shown
below.
Table 24: GE LightSpeed RT16 relative electron density calibration curve.
HU Rel. Density
-1000 0.001
-722 0.250
-81 0.945
37 1.010
261 1.090
763 1.360
3254 2.550
Calibration curve was interpolated linearly from the lowest to the highest HU.
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Figure 60: GE LightSpeed RT16 relative electron density calibration curve.
97
FCUP
Development of an independent MU calculation methodology for treatments with small fields
7.5 Algorithm validation
7.5.1 Depth calculation
To validate depth calculation, SSD was obtained with a MATLAB® algorithm and then
compared with the SSD from TPS. Both SSD values were rounded to the nearest integer,
in millimeters.
Table 25: Results of depth calculation validation using LUCY 3D QA phantom.
Gantry Rtn. (º) Couch Rtn. (º) TPS SSD (cm) Calculated
SSD (cm)
Difference
(mm)
0 0 93.8 93.9 1
90 0 91.6 91.6 0
210 0 94.8 94.8 0
0 20 93.8 93.9 1
80 90 90.7 90.7 0
210 340 94.4 94.5 1
A maximum difference of 1 mm was found between the SSD calculated by the TPS and
the SSD calculated with the MATLAB® algorithm.
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7.5.2 MU calculation without heterogeneity correction
Results of MU calculation without heterogeneity correction validation is given on appendix
C.1. The maximum difference registered was +2.07%. All the other values are below 2%
difference.
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Figure 61: Scatter plot of MU calculation differences between TPS MU and predicted MU for static fields
(orange dots) and arcs (green dots) in TrueBeam™ STx.
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Figure 62: Scatter plot of MU calculation differences between TPS MU and predicted MU for static fields
(orange dots) and arcs (green dots) in Novalis Tx™.
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The results are within the expected because the algorithm developed without
heterogeneity correction presented the same behaviour as CDC algorithm. For similar
calculation algorithms for homogeneous conditions, AAPM TG-114 states a tolerance of
2% for fields using the same patient or phantom geometry with minimal field shaping
[48].
7.5.3 MU calculation with heterogeneity correction
Manual effective depth calculation
For static fields, due to QUASAR™ thorax phantom simple geometry, effective depth can
be calculated easily if RED value from the phantom and inserts are known.
QUASAR™ thorax phantom measures 30 cm width and 20 cm height [47]. Ionization
chamber is placed at the center of the phantom. In a lateral beam that crosses the lung
insert (gantry rotation 90º), the distance from the isocenter to the phantom surface is
15 cm (half of the phantom width). The lung insert measures 8 cm diameter. That means
there are 7 cm of phantom material and 8 cm of cedar wood between the isocenter and
the surface of the phantom. RED values of these regions are obtained tracing a path
between the isocenter and the surface of the phantom (the voxel where the beam enters
on the phantom along the CAX). A graphical representation of that ray trace is given on
figure 63.
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Figure 63: RED values along the QUASAR™ thorax phantom between the isocenter and the surface of the
phantom, for a 90º static field.
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The average RED for the phantom material is very close to the water, 1.0397 and the
average RED of the cedar wood is 0.3995.
Effective depth of the lateral field is:
deff =
∑
i
ρeli × xi = (1.0397×7 cm) + (0.3995×8 cm) = 10.47 cm
However, the effective depth calculated in MATLAB® for this field is 10.50 cm because
the external marker placed on the left side of the phantom is partially inside the external
contour, as can be seen in figure 64. The marker presence also can be seen in figure 63.
The spike at the end of the plot on the right side corresponds to the marker.
Including the external marker on the external contour increases the effective depth
because the marker is composed by a dense material.
Figure 64: External marker partially inside the external contour of the phantom.
For the posterior beam that crosses the bone insert (gantry rotation 180º), the distance
from the isocenter to the phantom surface is 10 cm (half of the phantom height) [47]. The
bone insert measures 2 cm diameter. That means there are 8 cm of phantom material
and 2 cm of bone between the isocenter and the surface of the phantom. A graphical
representation of the ray trace between these two locations is given on figure 65.
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Figure 65: RED values along the QUASAR™ thorax phantom between the isocenter and the surface of the
phantom, for a 180º static field.
The average RED for the phantom material is 1.0411, which is very close to the previous
RED obtained for the lateral beam, with a difference of only 0.0014. The RED for the bone
insert is 1.3411, which is very close to the 1.36 RED value announced by the phantom
manufacturer.
Effective depth of the posterior field is:
deff =
∑
i
ρeli × xi = (1.0411×8 cm) + (1.3411×2 cm) = 11.01 cm
Effective depth calculated in MATLAB® for this field is 11.13 cm. The difference might be
explained because external contour includes the phantom edge, as shown on figure 66.
External contour by default is drawn automatically in Eclipse™ workspace and is based
on threshold values. The lower threshold for the external contour is -350 HU. Everything
that is above this value is drawn as external contour.
102
FCUP
Development of an independent MU calculation methodology for treatments with small fields
Figure 66: Phantom edge included in the external contour of the phantom. The external contour is
represented by the green line.
The phantom edge is noticeable in figure 65. The RED drop at the end of the plot is the
phantom edge, which has a RED value inferior to the phantom material:
Figure 67: RED drop caused by the phantom edge.
Including the phantom edge on the external contour of the phantom increases the
effective depth and might be responsible for the 1.2 mm difference between the effective
depth calculated manually and calculated in MATLAB®.
Another factor that needs to be taken into account is the couch attenuation. The couch
model was added as a structure with custom density in Eclipse™ TPS for QUASAR™
thorax phantom plans. TrueBeam™ STx and Novalis Tx™ have a similar couch with a
superior and inferior surface and a hollow interior, as shown below:
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Figure 68: TrueBeam™ STx couch. The hollow interior and the couch surface are represented in magenta
and orange contours with a RED of 0.0447 and 0.3224 respectively.
A couch attenuation of 5 mm of water equivalent was found for both LINACs when the
beam is incident perpendicularly to the couch. This value was added to the effective
depth calculated for the posterior 180º static field. However, for the arc between 0º and
180º, the couch attenuation varies with the gantry angle. In this particular case, the couch
starts attenuating the beam when the gantry angle reaches 113º. Effective depth from
113º to 180º with and without couch attenuation is shown on figure 69a and its difference
on figure 69b. As explained earlier, arcs are segmented into multiple static fields with 1º
gantry angle resolution. For each angle, the couch attenuation was calculated and the
value was added to the effective depth.
For patient plans, the couch model should be exported from Eclipse™ with custom
density assigned. Any other structures that attenuate the beam should be included also.
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Figure 69: On the left: effective depth calculated between the gantry angle where the couch starts
attenuating the beam (113º) and the end of the beam (180º). On the right: difference between the effective
depth with and without couch attenuation, for the same gantry angles. The green line on (b) is the difference
between the blue line and the red line on (a). Calculated for the TrueBeam™ STx couch and QUASAR™
thorax phantom using a arc between 0º and 180º for the heterogeneity correction validation tests.
Static fields and arcs used to validate MU calculation with heterogeneity correction for
TrueBeam™ STx and Novalis Tx™ are given on appendix B.2.
Output correction factors for PTW PinPoint 31016
The output correction factors for the PTW PinPoint 31016 were obtained using the same
methodology of PTW microDiamond 60019. Cone equivalent square field size was
determined with equation (6.3). Correction factors were fitted into a two term exponential
curve, defined in equation (6.4). The following curve fit coefficients were obtained:
Coefficients (with 95% confidence bounds):
a = 0.3626 (0.3091, 0.4162)
b = -0.2229 (-0.2382, -0.2076)
c = 1 (0.9989, 1.001)
d = 5.981e-08 (-2.018e-05, 2.03e-05)
Table 26: Cone size with the equivalent square field size and the corresponding OF correction factor, for 6
FFF, 10 FFF and 6X-SRS energies using PTW PinPoint 31016 detector.
Cone Size (mm) Eqv. Square Field Size (mm) Correction factor
10.0 8.862 1.05030
12.5 11.078 1.03070
15.0 13.293 1.01874
17.5 15.509 1.01144
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Figure 70: OF correction factors for PTW PinPoint 31016 as a function of the equivalent square field size.
Red dots are the cones equivalent square field size. Valid for 6 FFF, 10 FFF and 6X SRS energies.
MU calculation results
Results of MU calculation with heterogeneity correction validation is given on appendix
C.2. For the sake of clarity, results will be divided in three incidences: the 90º lateral
beam, the 180º posterior beam and the arc between 0º and 180º clockwise.
• 90º lateral beam: This beam crosses 8 cm of cedar wood and is expected to give
larger deviations when compared to CDC calculations. The developed algorithm
underestimates the dose for TrueBeam™ STx with an average of -1.70% for 6 FFF
and -3.35% for 10 FFF. In Novalis Tx™ the dose was overestimated with an
average of 0.95%. The dose underestimation for 10 FFF might be related with the
energy of the beam. As AAPM Report nº 85 states, heterogeneity corrections are
more complex and even contradictory as the energy increases [49]. However, this
should not be a concern because most of the beams do not cross air cavities
before reaching the target volume in radiosurgery treatments and 10 MV is not
used too often as 6 MV in this type of stereotactic treatments;
• 180º posterior beam: This beam crosses 2 cm of the bone insert. A dose
underestimation was found for TrueBeam™ STx with an average of -0.31% for 6
FFF and -2.13% for 10 FFF. However, for Novalis Tx™, an average of 3.76% was
obtained;
• Arc between 0º and 180º clockwise: The developed algorithm overestimated the
dose for 6 FFF and underestimated the dose for 10 FFF, with an average of 1.54%
and -0.90% respectively. For Novalis Tx™, the average was 3.97%.
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From the results we can observe that the developed algorithm always overestimates the
dose for Novalis Tx™, especially for the 90º and 180º static fields. For TrueBeam™
STx, it always underestimated the dose for the 90º and 180º static fields. For the arc, it
overestimated for 6 FFF and underestimated for 10 FFF.
The maximum difference registered was 4.36% for the clockwise arc in the Novalis Tx™
using 6X SRS energy. None of the observed differences exceeded the 5% tolerance
stated by AAPM TG-114. This is the uncertainty widely accepted between the difference
of the planned dose and the delivered dose, for an effective radiation treatment [48].
0 5 10 15 20 25
Fields
-5
-4
-3
-2
-1
0
1
2
3
4
5
D
iff
er
en
ce
 fr
om
 p
re
di
ct
ed
 d
os
e 
to
 a
bs
or
be
d 
do
se
 (%
) 6 FFF - 90º
6 FFF - 180º
6 FFF - arc
10 FFF - 90º
10 FFF - 180º
10 FFF - arc
Figure 71: Scatter plot of dose calculation difference between predicted dose and absorbed dose for static
fields and arcs in TrueBeam™ STx.
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Figure 72: Scatter plot of dose calculation difference between predicted dose and absorbed dose for static
fields and arcs in Novalis Tx ™.
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7.5.4 Patient plans MU verification
A total of 12 patients (6 for each LINAC) were chosen to validate the software developed
during this work. The results are presented on appendix D.1 for TrueBeam™ STx and
on appendix D.2 for Novalis Tx™. Equations (6.50) and (6.51), given on chapter 6.2.6.4,
were used to calculate the differences between the MU calculated by the CDC and the
MU calculated by the developed software with and without heterogeneity correction.
The maximum difference found for MU calculation without heterogeneity correction was
+1.40% on patient ID 7 from Novalis Tx™ (absolute average of 0.81% for all patients).
The obtained results are within the expected because as stated before, the developed
algorithm has a similar behaviour to the CDC algorithm when not using heterogeneity
correction.
For MU calculation with heterogeneity correction, the maximum difference was +6.20%
on patient ID 2 from TrueBeam™ STx and +5.91% on patient ID 12 from Novalis Tx™
(absolute average of 3.57% for all patients). In fact, these were the only patients whose
deviation was higher than 5% for a treatment field. Figures 73 and 74 represent
graphically the differences from CDC to the developed algorithm, with and without
heterogeneity correction.
The developed algorithm always calculates more MU than CDC to compensate the tissue
attenuation. Varian states that the dose error because bone attenuation is approximately
1.2% [34], however, the overall attenuation is higher.
Figure 73: Differences from CDC calculation to the developed algorithm with and without heterogeneity
correction in TrueBeam™ STx. Each background colour corresponds to a different patient. Green and blue
dots are the differences from CDC to the developed algorithm with and without heterogeneity correction for
each treatment field, respectively.
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Figure 74: Differences from CDC calculation to the developed algorithm with and without heterogeneity
correction in Novalis Tx™. Each background colour corresponds to a different patient. Green and blue dots
are the differences from CDC to the developed algorithm with and without heterogeneity correction for each
treatment field, respectively.
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8 Conclusions
The main objective of this dissertation was the development of an independent MU
calculator for stereotactic treatments with Varian and BrainLAB cone systems in a Varian
TrueBeam™ STx and Varian Novalis Tx™. The goal of this independent MU verification
is to ensure that the primary MU calculation is sufficiently accurate for the safe and
effective treatment of patients.
In order to develop the independent MU calculator, TMR, OAR and OF measurements
were taken in both LINACs using 6 FFF and 10 FFF energies for TrueBeam™ STx and
6X SRS energy for Novalis Tx™, following the dosimetry formalism for small fields
proposed by the TRS-483. Additionally, FWHM of stereotactic cones was measured in
TrueBeam™ STx using 6 FFF energy. A calibration curve was acquired to establish the
relation between the film darkening and the absorbed dose.
The developed algorithm without heterogeneity was evaluated against CDC calculations
for multiple plans using static fields and arcs in both LINACs. A 2% tolerance was
established from AAPM TG-114. Since the calculation method from both algorithms is
very similar, the results are within the expected with a maximum difference of +2.07% in
one test from the algorithm validation without heterogeneity correction. For patients, the
maximum deviation from CDC algorithm was +1.40%.
Regarding the heterogeneity correction, the software developed was validated with
measurements in-phantom with an ionization chamber, for static fields and arcs. The 5%
tolerance established was based on AAPM TG-114. A maximum difference of +4.36%
was found in the validation tests. For patients, a maximum difference of +6.20% and
+5.91% was found in two treatment fields of different patients, for TrueBeam™ STx and
Novalis Tx™ respectively. These were the only treatment fields from the patient plans
that exceeded the tolerance accepted for calculation with heterogeneity correction, in
comparison with CDC calculation. The heterogeneity correction gives the ability to the
dosimetrists and physicists to ponder different beam incidences in order to chose beams
that crosses structures with less radiation attenuation.
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9 Future work
Heterogeneity correction was the only CDC algorithm limitation that was implemented in
the developed algorithms. Others limitations such as the beam obliquity and the absence
of backscatter near cavities or surfaces where the beam exits are still present. Another
limitation of the developed algorithms is related to the TMR calculation. TMR can’t be
calculated if the depth of the field is greater than the maximum TMR depth measured.
For future work, these limitations should be taken into account.
Regarding algorithm validation with heterogeneity correction, dose measurements with
an ionization chamber were performed only for stereotactic cones greater or equal than
10 mm due to the detector active volume size. For future work, the algorithm should be
validated for smaller cones sizes (between 4 and 7.5 mm) with another dosimeter type
(for example, radiochromic films).
Some improvements on relative dosimetry could be done using a PTW T-REF chamber,
a new reference detector chamber for small fields. This transmission chamber can be
placed directly under the LINAC head without interfering with the beam [50].
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Appendices
A Smoothed TMR curves
A.1 TrueBeam™
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Figure 75: TrueBeam™ STx smoothed TMR with a local regression method using weighted linear least
squares and a 2nd degree polynomial model for 6 FFF energy.
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Figure 76: TrueBeam™ STx TMR fitted into a two-term exponential model for 6 FFF energy.
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Figure 77: TrueBeam™ STx smoothed TMR with a local regression method using weighted linear least
squares and a 2nd degree polynomial model for 10 FFF energy.
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Figure 78: TrueBeam™ STx smoothed TMR fitted into a two-term exponential model for 10 FFF energy.
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A.2 Novalis Tx™
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Figure 79: Novalis Tx™ smoothed TMR with a local regression method using weighted linear least squares
and a 2nd degree polynomial model for 6X SRS energy.
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Figure 80: Novalis Tx™ smoothed TMR fitted into a two-term exponential model for 6X SRS energy.
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B Beam parameters used in algorithm validation
B.1 Without heterogeneity correction
Table 27: Static field parameters used for MU calculation without heterogeneity correction validation in
TrueBeam™ STx LINAC. All fields are normalized to a isocenter dose of 8 Gy.
Energy Cone Size (mm) Gantry Rtn. (º) Couch Rtn. (º) TPS MU
6 FFF 17.5 0 0 1079.2
6 FFF 17.5 90 0 1212.7
6 FFF 17.5 210 0 1023.1
6 FFF 17.5 0 20 1074.2
6 FFF 17.5 80 90 1266.1
6 FFF 17.5 210 340 1040.5
6 FFF 10 0 0 1197.9
6 FFF 10 90 0 1353.1
6 FFF 10 210 0 1133.2
6 FFF 10 0 270 1197.0
6 FFF 10 90 45 1502.0
6 FFF 10 210 320 1197.0
6 FFF 5 0 0 1487.3
6 FFF 5 90 0 1689.6
6 FFF 5 210 0 1403.6
6 FFF 5 0 45 1487.3
6 FFF 5 90 30 1843.0
6 FFF 5 210 310 1513.4
10 FFF 17.5 0 0 995.3
10 FFF 17.5 90 0 1089.5
10 FFF 17.5 210 0 954.1
10 FFF 15 0 0 1030.7
10 FFF 15 90 0 1129.9
10 FFF 15 210 0 987.4
10 FFF 12.5 0 0 1076.9
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Table 27: Static field parameters used for MU calculation without heterogeneity correction validation in
TrueBeam™ STx LINAC. All fields are normalized to a isocenter dose of 8 Gy.
Energy Cone Size (mm) Gantry Rtn. (º) Couch Rtn. (º) TPS MU
10 FFF 12.5 90 0 1182.7
10 FFF 12.5 210 0 1030.9
10 FFF 10 0 0 1162.1
10 FFF 10 90 0 1285.5
10 FFF 10 210 0 1116.1
10 FFF 7.5 0 0 1294.3
10 FFF 7.5 90 0 1429.3
10 FFF 7.5 210 0 1236.0
10 FFF 5 0 0 1576.0
10 FFF 5 90 0 1749.3
10 FFF 5 210 0 1501.9
10 FFF 4 0 0 1845.4
10 FFF 4 90 0 2052.8
10 FFF 4 210 0 1757.0
Table 28: Arc parameters used for MU calculation without heterogeneity correction validation in TrueBeam™
STx LINAC. All arcs are normalized to a isocenter dose of 8 Gy, calculated with 1º gantry resolution.
Energy Cone Size (mm) Gantry Rtn. (º) Couch Rtn. (º) TPS MU
6 FFF 17.5 11→ 124 20 1225.3
6 FFF 17.5 232→ 332 340 1025.4
6 FFF 17.5 112→ 0 90 1200.7
6 FFF 15 300→ 120 30 902.6
6 FFF 15 107→ 320 85 884.0
6 FFF 15 181→ 67.5 320 964.3
6 FFF 12.5 0→ 120 30 1241.2
6 FFF 12.5 300→ 70 45 1213.0
6 FFF 12.5 181→ 340 340 978.9
6 FFF 10 11→ 124 20 1376.1
6 FFF 10 232→ 332 340 1142.7
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Table 28: Arc parameters used for MU calculation without heterogeneity correction validation in TrueBeam™
STx LINAC. All arcs are normalized to a isocenter dose of 8 Gy, calculated with 1º gantry resolution.
Energy Cone Size (mm) Gantry Rtn. (º) Couch Rtn. (º) TPS MU
6 FFF 10 112→ 0 90 1347.2
6 FFF 7.5 0→ 120 90 1205.1
6 FFF 7.5 300→ 70 0 1406.4
6 FFF 7.5 181→ 340 270 1146.2
6 FFF 5 300→ 120 30 1194.7
6 FFF 5 107→ 320 85 1166.3
6 FFF 5 181→ 67.5 320 1286.8
6 FFF 4 0→ 120 90 1580.1
6 FFF 4 300→ 70 0 1856.6
6 FFF 4 181→ 340 270 1500.1
10 FFF 17.5 11→ 124 20 1101.4
10 FFF 17.5 232→ 332 340 958.5
10 FFF 17.5 112→ 0 90 1084.3
10 FFF 15 300→ 120 30 899.4
10 FFF 15 107→ 320 85 900.0
10 FFF 15 181→ 67.5 320 935.3
10 FFF 12.5 0→ 120 30 1157.2
10 FFF 12.5 300→ 70 45 1136.6
10 FFF 12.5 181→ 340 340 962.3
10 FFF 10 11→ 124 20 1303.3
10 FFF 10 232→ 332 340 1124.0
10 FFF 10 112→ 0 90 1281.7
10 FFF 7.5 0→ 120 90 1230.5
10 FFF 7.5 300→ 70 0 1393.4
10 FFF 7.5 181→ 340 270 1182.0
10 FFF 5 300→ 120 30 1322.0
10 FFF 5 107→ 320 85 1297.8
10 FFF 5 181→ 67.5 320 1401.6
10 FFF 4 0→ 120 90 1752.4
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Table 28: Arc parameters used for MU calculation without heterogeneity correction validation in TrueBeam™
STx LINAC. All arcs are normalized to a isocenter dose of 8 Gy, calculated with 1º gantry resolution.
Energy Cone Size (mm) Gantry Rtn. (º) Couch Rtn. (º) TPS MU
10 FFF 4 300→ 70 0 2003.3
10 FFF 4 181→ 340 270 1677.9
Table 29: Static field parameters used for MU calculation without heterogeneity correction validation in
Novalis Tx™ LINAC. All fields are normalized to a isocenter dose of 8 Gy.
Energy Cone Size (mm) Gantry Rtn. (º) Couch Rtn. (º) TPS MU
6X SRS 15 0 0 1093.0
6X SRS 15 90 0 1216.3
6X SRS 15 210 0 1041.0
6X SRS 15 0 20 1089.5
6X SRS 15 80 90 1266.6
6X SRS 15 210 340 1058.2
6X SRS 10 0 0 117.5
6X SRS 10 90 0 1315.3
6X SRS 10 210 0 1120.8
6X SRS 10 0 20 1172.7
6X SRS 10 80 90 1376.1
6X SRS 10 210 340 1143.7
6X SRS 6 0 0 1379.9
6X SRS 6 90 0 1546.4
6X SRS 6 210 0 1310.3
6X SRS 6 0 20 1379.9
6X SRS 6 80 90 1620.1
6X SRS 6 210 340 1337.7
Table 30: Arc parameters used for MU calculation without heterogeneity correction validation in Novalis Tx™
LINAC. All arcs are normalized to a isocenter dose of 8 Gy, calculated with 1º gantry resolution.
Energy Cone Size (mm) Gantry Rtn. (º) Couch Rtn. (º) TPS MU
6X SRS 15 11-124 20 897.0
6X SRS 15 232-332 340 1002.1
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Table 30: Arc parameters used for MU calculation without heterogeneity correction validation in Novalis Tx™
LINAC. All arcs are normalized to a isocenter dose of 8 Gy, calculated with 1º gantry resolution.
Energy Cone Size (mm) Gantry Rtn. (º) Couch Rtn. (º) TPS MU
6X SRS 15 112-0 90 889.0
6X SRS 12.5 11-124 20 1334.5
6X SRS 12.5 232-332 340 992.5
6X SRS 12.5 112-0 90 1074.2
6X SRS 10 11-124 20 1334.5
6X SRS 10 232-332 340 1129.8
6X SRS 10 112-0 90 1310.3
6X SRS 7.5 11-124 20 1426.7
6X SRS 7.5 232-332 340 1120.0
6X SRS 7.5 112-0 90 1215.9
6X SRS 6 11-124 20 1115.6
6X SRS 6 232-332 340 1261.4
6X SRS 6 112-0 90 1100.1
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B.2 With heterogeneity correction
Table 31: Beam parameters used for dose calculation with heterogeneity correction validation in TrueBeam™
STx LINAC. All fields are normalized to a isocenter dose of 8 Gy. Arcs are calculated with 1º gantry
resolution.
Energy Cone Size (mm) Gantry Rtn. (º) Couch Rtn. (º) TPS MU
6 FFF 17.5 90 0 1739.0
6 FFF 17.5 180 0 1332.8
6 FFF 17.5 0→ 180 0 1522.1
6 FFF 15 90 0 1791.0
6 FFF 15 180 0 1367.0
6 FFF 15 0→ 180 0 1564.1
6 FFF 12.5 90 0 1848.6
6 FFF 12.5 180 0 1406.1
6 FFF 12.5 0→ 180 0 1611.1
6 FFF 10 90 0 1966.3
6 FFF 10 180 0 1494.3
6 FFF 10 0→ 180 0 1710.4
10 FFF 17.5 90 0 1437.9
10 FFF 17.5 180 0 1170.5
10 FFF 17.5 0→ 180 0 1297.8
10 FFF 15 90 0 1499.2
10 FFF 15 180 0 1216.0
10 FFF 15 0→ 180 0 1350.4
10 FFF 12.5 90 0 1579.4
10 FFF 12.5 180 0 1275.1
10 FFF 12.5 0→ 180 0 1419.1
10 FFF 10 90 0 1730.4
10 FFF 10 180 0 1392.1
10 FFF 10 0→ 180 0 1553.1
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Table 32: Beam parameters used for dose calculation with heterogeneity correction validation in Novalis Tx™
LINAC. All fields are normalized to a isocenter dose of 8 Gy. Arcs are calculated with 1º gantry resolution.
Energy Cone Size (mm) Gantry Rtn. (º) Couch Rtn. (º) TPS MU
6X SRS 15 90 0 1688.7
6X SRS 15 180 0 1327.7
6X SRS 15 0→ 180 0 1521.3
6X SRS 12.5 90 0 1754.5
6X SRS 12.5 180 0 1374.9
6X SRS 12.5 0→ 180 0 1553.3
6X SRS 10 90 0 1843.8
6X SRS 10 180 0 1438.9
6X SRS 10 0→ 180 0 1649.4
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C Algorithm validation results
C.1 Without heterogeneity correction
Table 33: Results of MU calculation without heterogeneity correction validation in TrueBeam™ STx LINAC
using static fields.
Energy Cone Size
(mm)
Gantry
Rtn. (º)
Couch
Rtn. (º)
TPS MU Predicted
MU
Difference
(%)
6 FFF 17.5 0 0 1079.2 1081.9 +0.25
6 FFF 17.5 90 0 1212.7 1231.4 +1.54
6 FFF 17.5 210 0 1023.1 1029.1 +0.59
6 FFF 17.5 0 20 1074.2 1081.9 +0.72
6 FFF 17.5 80 90 1266.1 1292.3 +2.07
6 FFF 17.5 210 340 1040.5 1046.6 +0.59
6 FFF 10 0 0 1197.9 1193.8 -0.34
6 FFF 10 90 0 1353.1 1362.1 +0.67
6 FFF 10 210 0 1133.2 1133.0 -0.02
6 FFF 10 0 270 1197.0 1193.8 -0.27
6 FFF 10 90 45 1502.0 1510.6 +0.57
6 FFF 10 210 320 1197.0 1200.6 +0.30
6 FFF 5 0 0 1487.3 1499.4 +0.81
6 FFF 5 90 0 1689.6 1722.7 +1.96
6 FFF 5 210 0 1403.6 1418.5 +1.06
6 FFF 5 0 45 1487.3 1499.4 +0.81
6 FFF 5 90 30 1843.0 1874.6 +1.71
6 FFF 5 210 310 1513.4 1536.8 +1.55
10 FFF 17.5 0 0 995.3 993.9 -0.14
10 FFF 17.5 90 0 1089.5 1098.3 +0.81
10 FFF 17.5 210 0 954.1 957.4 +0.35
10 FFF 15 0 0 1030.7 1033.7 +0.29
10 FFF 15 90 0 1129.9 1142.6 +1.12
10 FFF 15 210 0 987.4 994.2 +0.69
10 FFF 12.5 0 0 1076.9 1085.0 +0.75
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Table 33: Results of MU calculation without heterogeneity correction validation in TrueBeam™ STx LINAC
using static fields.
Energy Cone Size
(mm)
Gantry
Rtn. (º)
Couch
Rtn. (º)
TPS MU Predicted
MU
Difference
(%)
10 FFF 12.5 90 0 1182.7 1201.3 +1.57
10 FFF 12.5 210 0 1030.9 1042.2 +1.10
10 FFF 10 0 0 1162.1 1155.9 -0.53
10 FFF 10 90 0 1285.5 1286.2 +0.05
10 FFF 10 210 0 1116.1 1114.3 -0.16
10 FFF 7.5 0 0 1294.3 1294.3 0.00
10 FFF 7.5 90 0 1429.3 1440.0 +0.75
10 FFF 7.5 210 0 1236.0 1240.7 +0.38
10 FFF 5 0 0 1576.0 1586.7 +0.68
10 FFF 5 90 0 1749.3 1775.8 +1.51
10 FFF 5 210 0 1501.9 1517.4 +1.03
10 FFF 4 0 0 1845.4 1822.6 -1.24
10 FFF 4 90 0 2052.8 2054.2 +0.07
10 FFF 4 210 0 1757.0 1739.7 -0.98
Table 34: Results of MU calculation without heterogeneity correction validation in TrueBeam™ STx LINAC
using arcs.
Energy Cone Size
(mm)
Gantry
Rtn. (º)
Couch
Rtn. (º)
TPS MU Predicted
MU
Difference
(%)
6 FFF 17.5 11-124 20 1225.3 1248.3 +1.88
6 FFF 17.5 232-332 340 1025.4 1033.7 +0.81
6 FFF 17.5 112-0 90 1200.7 1220.8 +1.67
6 FFF 15 300-120 30 902.6 910.2 +0.84
6 FFF 15 107-320 85 884.0 891.9 +0.89
6 FFF 15 181-67.5 320 964.3 972.4 +0.84
6 FFF 12.5 0-120 30 1241.2 1263.1 +1.76
6 FFF 12.5 300-70 45 1213.0 1230.7 +1.46
6 FFF 12.5 181-340 340 978.9 988.9 +1.03
6 FFF 10 11-124 20 1376.1 1381.6 +0.40
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Table 34: Results of MU calculation without heterogeneity correction validation in TrueBeam™ STx LINAC
using arcs.
Energy Cone Size
(mm)
Gantry
Rtn. (º)
Couch
Rtn. (º)
TPS MU Predicted
MU
Difference
(%)
6 FFF 10 232-332 340 1142.7 1138.2 -0.39
6 FFF 10 112-0 90 1347.2 1350.5 +0.24
6 FFF 7.5 0-120 90 1205.1 1206.8 +0.14
6 FFF 7.5 300-70 0 1406.4 1411.4 +0.36
6 FFF 7.5 181-340 270 1146.2 1149.0 +0.24
6 FFF 5 300-120 30 1194.7 1208.3 +1.14
6 FFF 5 107-320 85 1166.3 1180.5 +1.22
6 FFF 5 181-67.5 320 1286.8 1300.0 +1.03
6 FFF 4 0-120 90 1580.1 1563.2 -1.07
6 FFF 4 300-70 0 1856.6 1850.7 +0.32
6 FFF 4 181-340 270 1500.1 1482.3 -1.19
10 FFF 17.5 11-124 20 1101.4 1110.2 +0.80
10 FFF 17.5 232-332 340 958.5 960.7 +0.23
10 FFF 17.5 112-0 90 1084.3 1091.2 +0.64
10 FFF 15 300-120 30 899.4 903.8 +0.49
10 FFF 15 107-320 85 900.0 894.8 -0.58
10 FFF 15 181-67.5 320 935.3 939.7 +0.47
10 FFF 12.5 0-120 30 1157.2 1171.9 +1.27
10 FFF 12.5 300-70 45 1136.6 1148.6 +1.06
10 FFF 12.5 181-340 340 962.3 970.1 +0.81
10 FFF 10 11-124 20 1303.3 1301.4 -0.15
10 FFF 10 232-332 340 1124.0 1118.3 -0.51
10 FFF 10 112-0 90 1281.7 1278.5 -0.25
10 FFF 7.5 0-120 90 1230.5 1230.8 +0.02
10 FFF 7.5 300-70 0 1393.4 1394.7 +0.09
10 FFF 7.5 181-340 270 1182.0 1183.8 +0.15
10 FFF 5 300-120 30 1322.0 1339.6 +1.33
10 FFF 5 107-320 85 1297.8 1316.2 +1.43
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Table 34: Results of MU calculation without heterogeneity correction validation in TrueBeam™ STx LINAC
using arcs.
Energy Cone Size
(mm)
Gantry
Rtn. (º)
Couch
Rtn. (º)
TPS MU Predicted
MU
Difference
(%)
10 FFF 5 181-67.5 320 1401.6 1417.7 +1.15
10 FFF 4 0-120 90 1752.4 1723.2 -1.67
10 FFF 4 300-70 0 2003.3 1979.0 -1.21
10 FFF 4 181-340 270 1677.9 1650.4 -1.64
Table 35: Results of MU calculation without heterogeneity correction validation in Novalis Tx™ LINAC using
static fields.
Energy Cone Size
(mm)
Gantry
Rtn. (º)
Couch
Rtn. (º)
TPS MU Predicted
MU
Difference
(%)
6X SRS 15 0 0 1093.0 1095.8 +0.26
6X SRS 15 90 0 1216.3 1231.7 +1.27
6X SRS 15 210 0 1041.0 1048.9 +0.76
6X SRS 15 0 20 1089.5 1095.8 +0.58
6X SRS 15 80 90 1266.6 1287.8 +1.67
6X SRS 15 210 340 1058.2 1069.5 +1.07
6X SRS 10 0 0 117.5 1179.8 +0.62
6X SRS 10 90 0 1315.3 1331.9 +1.26
6X SRS 10 210 0 1120.8 1131.4 +0.95
6X SRS 10 0 20 1172.7 1179.8 +0.61
6X SRS 10 80 90 1376.1 1395.2 +1.39
6X SRS 10 210 340 1143.7 1149.2 +0.48
6X SRS 6 0 0 1379.9 1390.1 +0.74
6X SRS 6 90 0 1546.4 1570.4 +1.55
6X SRS 6 210 0 1310.3 1324.1 +1.05
6X SRS 6 0 20 1379.9 1390.1 +0.74
6X SRS 6 80 90 1620.1 1641.8 +1.34
6X SRS 6 210 340 1337.7 1345.7 +0.60
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Table 36: Results of MU calculation without heterogeneity correction validation in Novalis Tx™ LINAC using
arcs.
Energy Cone Size
(mm)
Gantry
Rtn. (º)
Couch
Rtn. (º)
TPS MU Predicted
MU
Difference
(%)
6X SRS 15 11-124 20 897.0 908.5 +1.28
6X SRS 15 232-332 340 1002.1 1011.2 +0.91
6X SRS 15 112-0 90 889.0 899.4 +1.17
6X SRS 12.5 11-124 20 1334.5 1270.5 +1.35
6X SRS 12.5 232-332 340 992.5 999.5 +0.71
6X SRS 12.5 112-0 90 1074.2 1083.3 +0.85
6X SRS 10 11-124 20 1334.5 1350.4 +1.19
6X SRS 10 232-332 340 1129.8 1136.1 +0.56
6X SRS 10 112-0 90 1310.3 1323.3 +0.99
6X SRS 7.5 11-124 20 1426.7 1432.5 +0.41
6X SRS 7.5 232-332 340 1120.0 1119.4 -0.05
6X SRS 7.5 112-0 90 1215.9 1216.9 +0.08
6X SRS 6 11-124 20 1115.6 1125.1 +0.85
6X SRS 6 232-332 340 1261.4 1268.1 +0.53
6X SRS 6 112-0 90 1100.1 1108.6 +0.77
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C.2 With heterogeneity correction
Table 37: Results of dose calculation with heterogeneity correction validation in TrueBeam™ STx LINAC.
Energy Cone Size
(mm)
Gantry
Rtn. (º)
TPS MU Predicted
Dose
(Gy)
Absorbed
Dose (Gy)
Difference
(%)
6 FFF 17.5 90 1739.0 10.105 10.268 -1.59
6 FFF 17.5 180 1332.8 7.304 7.304 0.00
6 FFF 17.5 0-180 1522.1 8.063 7.928 +1.70
6 FFF 15 90 1791.0 10.127 10.364 -2.29
6 FFF 15 180 1367.0 7.297 7.327 -0.41
6 FFF 15 0-180 1564.1 8.065 7.963 +1.28
6 FFF 12.5 90 1848.6 10.135 10.383 -2.39
6 FFF 12.5 180 1406.1 7.264 7.302 -0.52
6 FFF 12.5 0-180 1611.1 8.040 7.947 +1.17
6 FFF 10 90 1966.3 10.304 10.361 -0.55
6 FFF 10 180 1494.3 7.374 7.396 -0.30
6 FFF 10 0-180 1710.4 8.158 7.997 +2.01
10 FFF 17.5 90 1437.9 9.602 9.937 -3.37
10 FFF 17.5 180 1170.5 7.470 7.628 -2.07
10 FFF 17.5 0-180 1297.8 8.012 8.135 -1.51
10 FFF 15 90 1499.2 9.618 9.989 -3.71
10 FFF 15 180 1216.0 7.453 7.624 -2.24
10 FFF 15 0-180 1350.4 8.053 8.140 -1.07
10 FFF 12.5 90 1579.4 9.618 10.011 -3.93
10 FFF 12.5 180 1275.1 7.417 7.590 -2.28
10 FFF 12.5 0-180 1419.1 8.027 8.112 -1.05
10 FFF 10 90 1730.4 9.824 10.064 -2.38
10 FFF 10 180 1392.1 7.692 7.692 -1.92
10 FFF 10 0-180 1553.1 8.180 8.177 +0.04
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Table 38: Results of dose calculation with heterogeneity correction validation in Novalis Tx™ LINAC.
Energy Cone Size
(mm)
Gantry
Rtn. (º)
TPS MU Predicted
Dose
(Gy)
Absorbed
Dose (Gy)
Difference
(%)
6X SRS 15 90 1688.7 9.857 9.743 +1.17
6X SRS 15 180 1327.7 7.379 7.079 +4.24
6X SRS 15 0-180 1521.3 8.028 7.734 +3.80
6X SRS 12.5 90 1754.5 9.824 9.819 +0.05
6X SRS 12.5 180 1374.9 7.360 7.109 +3.53
6X SRS 12.5 0-180 1553.3 8.046 7.756 +3.74
6X SRS 10 90 1843.8 9.980 9.821 +1.62
6X SRS 10 180 1438.9 7.345 7.095 +3.52
6X SRS 10 0-180 1649.4 8.071 7.734 +4.36
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D Patient plans MU verification
D.1 TrueBeam™ STx patient plans
Figure 81: Patient ID 1.
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Figure 82: Patient ID 2.
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Figure 83: Patient ID 3.
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Figure 84: Patient ID 4.
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Figure 85: Patient ID 5.
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Figure 86: Patient ID 6.
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D.2 Novalis Tx™ patient plans
Figure 87: Patient ID 7.
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Figure 88: Patient ID 8.
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Figure 89: Patient ID 9.
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Figure 90: Patient ID 10.
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Figure 91: Patient ID 11.
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Figure 92: Patient ID 12.
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